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Objectives 
The 1998 National Drug Control Strategy established an ambitious national agenda for reducing illicit 
drug use by 25 percent as of 2002 and by 50 percent as of 2007. When it established those targets, 
the Office of National Drug Control Policy recognized that achieving its goals would quire  a 
multifaceted mixture of supply-based and demand-based programs. The nature of that mix was 
unknown, however, because there was no solid quantitative evidence of how supply-based and 
demand-based programs would interact to reduce substance abuse.  Indeed, there was no compelling 
evidence that available technology -  treatment, prevention, or law enforcement -  provided the means 
to achieve those targets. 
Are those targets achievable with the tools at the Nation’s disposal? This study does not attempt to 
answer that general question, but it does address a more narrow one:  How  can supply-based 
programs, which restrict drug availability, consequently increase drug prices, and reduce the initiation 
and continuation of drug abuse in the United States? To answer that question, the study has four 
parts.  Thisstudy: 
1.  Discusses how the prices of cocaine, heroin, marijuana and methamphetamine have changed over 
the last 20 years and assesses how law enforcement has affected those trends. 
2.  Estimates how changes in the prices of illicit drugs have influenced decisions by youth to initiate 
drug use. 
3.  Estimates how changes in the price of illicit drugs have affected continued use by hardcore and 
occasional drug users. 
4.  Projects the future prevalence of illicit drug use given different scenarios about the effectiveness 
of supply-based programs. 
Methods and Data 
This is an empirical study. Estimates of trends in drug prices come from an earlier study done by Abt 
Associates Inc. for the Office of National Drug Control Policy. That earlier study used data from two 
Drug Enforcement Administration data sources:  the System to Retrieve Information from Drug 
Evidence and the Domestic Monitor Program. Data about the initiation and continuation of drug use 
come from multiple administrations of the National Household Survey on Drug Abuse, mostly from 
the years 1988 through 1996. Those data, which identified the places for matching with the price 
data, were provided by the Research Triangle Institute by special agreement with the Substance 
Abuse Mental Health Services Administration. We thank both RTI  and SAMHSA  for their support. 
Data about drug use by hardcore users come from multiple administrations of the Drug  Use 
Forecasting data, mostly from 1989 through 1998.  We required raw data, before recoding done by a 
National Institute of Justice contractor, which NU  provided by special request.  We are also grateful 
to JCPSR and NU for their assistance. 
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affect the eventual probability that a youth would experiment with drugs and the age of 
experimentation if he or she did try an illicit substance. We used an ordered probit model, also 
developed especially for this study, to study how drug prices influenced decisions to use illicit 
substances by those who, at some time, had tried drugs at an  experimental level.  Finally, we used an 
ordered logistic model to analyze the relationship between illicit drug prices and the level of 
substance abuse among arrestees. 
Based on the statistical findings. we projected drug use into the years 2002  and 2007 based on 
different scenarios about how future drug prices will change from their present levels. The purpose of 
prices could approach the national target of reducing drug use by 50 percent as of 2007. 
this simulation was to estimate how closely a supply-based program that successfully  increased drug  / 
Findings 
Drug Prices 
There seems little doubt that the combination of source area programs, interdiction and domestic law 
enforcement have successfully increased the price of illicit drug products to levels that are many 
times higher than would otherwise prevail.  Cocaine, heroin and marijuana are basically agricultural 
products that quire  minimal inexpensive chemical processing. If it were not for law enforcement, 
they might sell for prices that are comparable to aspirin.  Instead, users pay many times the price of 
aspirin for typical doses. 
Still, the Nation’s ability to reduce drug availability and to increase drug prices appears to be limited. 
Since about 1988, the prices of cocaine, heroin and methamphetamine have all fallen or remained 
about the same, despite what was inaugurated in the late 1980s as a war on drugs.  The price of 
marijuana increased into the early 199Os, apparently because of a successful program of interdiction, 
but prices have declined since then as  domestic production has supplanted foreign production.  Thus, 
while law enforcement efforts have maintained high domestic prices for illicit substances, an 
expansion of law enforcement resources in the 1990s has not had a commensurate effect on drug 
prices. 
0 
Elasticity of  Demand 
Marijuana 
When marijuana has been relatively unavailable, as reflected in high marijuana prices during the late 
1980s and early 199Os, young Americans have been less likely to experiment with marijuana.  Thus, 
Americans who came of age during the early 1980s, when marijuana was relatively inexpensive, were 
more likely to try marijuana than were Americans who came of age in the early 199Os, when 
marijuana cost more.  Marijuana prices have fallen toward the end of the 1990~~  while the best 
evidence, available from several sources, indicates that youth have increasingly returned to marijuana 
use.  There seems to be strong evidence that price and availability influence the decisions of children 
and young adults to experiment with marijuana. 
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smaller the number of people who use marijuana at both weekly and occasional levels. This is true 
for members of households, who tend to use on an occasional basis, as well as for arrestees, who 
often use at a weekly level or higher. 
Cocaine 
There is some evidence that experimentation with cocaine is less frequent when cocaine prices are 
high, but the evidence is weak.  It would be a mistake to conclude that cocaine prices do not matter, 
however, because these data are not well suited to answering the question. Because cocaine prices 
have decreased fairly steadily since 1981, with just a few short-term perturbations, we could not 
readily distinguish the effect of  changes in cocaine prices from other secular trends. 
We did not find household members to be sensitive to cocaine prices.  However, arrestees reacted 
strongly to cocaine prices, decreasing their consumption when prices were high and increasing their 
consumption when prices were low. 
Heroin 
Heroin prices seemed to affect experimentation  with heroin. However, the effect was difficult to 
quantify because prices decreased fairly steadily from 1981 through 1998. We may not have been 
able to distinguish price responsiveness from other trends. 
It was not practical to study the demand for heroin using NHSDA data because so few respondents 
admitted heroin use.  Arrestees seemed to be only mildly responsive to heroin prices (and this 
relationship was statistically significant only at the 10 krcent level). 
a  Methamphetamines 
The NHSDA  did not ask the requisite questions about methamphetamine use, so the NHSDA data did 
not enter this analysis. Data from five DUF sites that had an appreciable amount of 
methamphetamine use indicated that methamphetamine users were very responsive to prices.  The 
prevalence of  methamphetamine use, both by heavy and occasional users, was greatest when prices 
were low and least when prices were high. 
Projections 
Marijuana 
The key question was whether or not the targets set by the National Strategy are obtainable. The 
good news is that the prevalence of marijuana use among  household users is likely to fall toward the 
national goal even if marijuana prices remain about the same as they were during the latter 1990s.  - 
The projected decline in use is much less for arrestees.  This follows because cohorts who came of 
age during the late 1970s and early 1980s were at the highest risk of experimenting with marijuana, 
but continued marijuana use is age sensitive.  As those high-risk cohorts grow older, fewer of their 
members will be active marijuana users.  Because initiation rates have been lower in the late 1980s 
and early 1990s, the disappearance of marijuana use by high-risk cohort members will not be offset 
by an equal increase in new marijuana users.  Higher marijuana prices would reinforce this change, of 
course; as of yet there is no evidence of domestic programs that would substantially increase 
marijuana prices by increasing the production and distribution costs of domestic producers. 
Vi1  Abt Associates Inc.  Drug Demand and Supply 
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use by eighth, tenth and twelfth graders who reported substance use to the Monitoring the Future 
Survey. Although the analysis reported here identified the beginning of that upturn in 
experimentation with marijuana use, our data ended in 1996, so we may have understated this 
resurgence in marijuana use.  The future may not be as bright as is painted here. 
Cocaine 
Similar patterns apply to cocaine, although for cocaine, the pattern is not so strong. We project a very 
gradual downward trend in cocaine use among household members.  Higher cocaine prices would 
reinforce that trend, but the analysis showed little if any consumer responsiveness by household 
members to increased cocaine prices. On the other hand, the analysis showed very strong price 
responsiveness  by arrestees, whose prevalence of cocaine use  was diminishing anyway.  Higher 
cocaine prices would reinforce that trend among heavy users, helping the Nation move toward its 
targets. 
Heroin 
We are less certain about projections for future heroin use.  The NHSDA  is not especially informative 
about heroin use, so we relied exclusively on the DUF  data.  Results suggested that the prevalence of 
heroin use would decline even without a price increase, apparently because heroin users are an aging 
population whose' use would decrease naturally. This conclusion is tentative, because relatively low- 
priced high-purity heroin, available since about 1995, may have induced increased use of heroin. 
Methamphetamine 
We are much less certain about future levels of methamphetamine use because of the small and 
narrowly based sample of arrestees.  Trends imply lower levels of future use among arrestees, and 
those trends would be reinforced by higher prices.  A problem with that inference is that it is based on 
past reports, which are very cyclical and do not point clearly toward less use.  Furthermore, 
methamphetamine use is currently limited to the West and (to a lesser extent) the Midwest.  It is 
difficult to anticipate whether or not methamphetamine use will spread to the rest of the country.  If it 
does, projections are probably in error. 
e 
Conclusions 
On the whole, prospective and confirmed drug users are sensitive to the price of drugs, so if the 
Nation can increase the effectiveness of source country programs, interdiction and domestic law 
enforcement, then drug abuse can be reduced appreciably.  Given experiences since the beginning of 
the war on drugs, which initiated major expansions in expenditures on supply-based programs, it 
seems more reasonable to conclude that the Nation will not be able to have any large future influence 
on decreasing the availability and increasing the price of illicit drugs.  Of course, this conclusions 
rests on observations of past trends, and it could be reversed by the introduction of technological 
advances, such as improved ways of detecting cocaine, better informed decisions about the placement 
of interdiction resources, and improved means of detecting domestic marijuana cultivation. But until 
those improvements happen, it is difficult to be sanguine that supply-based programs can be the major 
means by which the Nation reaches its 2002 and 2007 targets. 
On the other hand, there are reasons to believe that those targets can be obtained.  Excluding the use 
of alcohol and tobacco by youth, marijuana is by far the most widely abused illicit substance. 
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prices remain the same.  If marijuana prices could be returned to near the levels they attained in the 
early 199Os, then drug use in the household population would decrease even more. Thus, targets that 
pertain to the drug use by household members are within the Nation’s grasp, although supply-side 
programs alone cannot guarantee they will be reached.  e 
Trends by hardcore drug users are also encouraging. If the Nation can hold the line on the initiation 
of illicit drug use, preventing it from returning to the epidemic proportions experienced during earlier 
decades, then as more hardcore drug users age out of their addictions, there will be fewer 
replacements to take their place. These trends, by themselves, do not appear adequate to reach the 
expanded demand-based programs (especially treatment), the Nation can be hopeful, if not expectant, 
that drug abuse and its sequela will abate. 
I 
Nation’s targets for reducing hardcore drug use.  But with the reinforcement of supply-based and  / 
The fly in this prediction ointment is that our data stopped in 1996 and, of course, predictions had to 
be based on data as of that date.  In fact, the Monitoring the Future Survey (University of Michigan, 
1999) shows that lifetime prevalence of any illicit drug use by seniors reached a peak (since 1975) 
with the class of 1981 and decreased more or less steadily until the class of 1993.  Thereafter, 
experimentation has  increased more or less steadily through the class of  1999.  Our analysis may not 
fully account for this recent resurgence of use, although nothing in our findings contradict the recent 
trend reported by the MTF. 
The find conclusion, then, is the inevitable call for further research. If  it is important to monitor and 
explain trends, in order to predict the future, it seems  imperative to do this with the most recently 
available data. This study provides a template for how data obtained through annual surveys might be 
analyzed, to gain a better understanding of drug abuse.  > 
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Expenditures on antidrug programs, made collectively at all levels of government, exceeded $30 billion 
dollars per year at the end of the 1990s. Those expenditures were made on a myriad of demand-based and 
supply-based programs, often with little knowledge of how those programs directly affected the supply of 
and the demand for drugs, and with even less knowledge of how they interacted to affect drug abuse. 
Understandably, as it fashioned its response to rising drug use, the Nation was unwilling to wait for hard 
scientific evidence of  what “works” and “does not work.”  It was compelled to act. 
Nearly fifteen years into what was inaugurated as a war on drugs, the Nation can reflect on the successes 
and failures of its response to increased substance abuse. This study examines part of the puzzle.  Supply- 
based programs should reduce the availability of drugs to American consumers, either by preventing drugs 
from entering the country, or by increasing the cost of their production and distribution, or both. The 
success of supply-based programs should increase the price of illicit drugs, and if drug users act anything 
like the consumers of licit products, some should quit and others should reduce their use.  Demand-based 
programs should reinforce this effect by preventing people from becoming drug users in the first place, 
and by encouraging and facilitating active users to stop. 
Have supply-based and demand-based programs worked according to expectations  as enumerated in the 
National Strategy? This study examines how illicit drug prices have changed over the last twenty years as 
the United States has increased its expenditures on source country interventions, other forms of 
interdiction, and domestic law enforcement -  all in an attempt to restrict the availability of drugs to and 
within the United States. It examines how the resulting changes in prices have affected the initiation and 
continuation of illicit drug use, and it projects drug use based on  differing scenarios about the future 
success of supply-based and demand-based programs.  ’ 
This is an empirical study. Mathematical modeling and statistical analysis lead to inferences about how 
drug prices have affected and will affect the initiation and continuation of illicit drug use.  Drug prices 
come from an analysis of data in the System to Retrieve Drug Evidence (1981 through 1998). Data about 
the initiation and continuation of marijuana, cocaine and heroin use come from the National Household 
Survey on Drug Abuse (1982 through 1996). The Drug Use Forecasting system (1989 through 1998) 
provides data about the use of cocaine, heroin, marijuana and methamphetamines by arrestees, many of 
whom are heavy users based on self-reports. 
Objectives of this Study 
The 1998 National Drug Control Strategy specified five Goals and thirty-two supporting objectives that 
will guide the Government’s antidrug program over the next decade. The Strategy’s five Goals are 
encapsulated in a summary statement: Reduce the supply of and the demand for illicit drugs 50 percent by 
year-2007.  The Nation’s ability to meet this summaq goal depends partly on its ability to increase illicit 
drug prices through source country programs, transit zone interdiction, and domestic law enforcement.  If 
the Nation is successful at reducing drug supply and hence increasing drug prices, the question becomes: 
How will increased prices affect the demand for illicit substances? That is the central question to be 
answered in this study. 
1  Abt Associates Inc.  Drug Demand and Supply 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not In addition to that summary statement, the Office of National Drug Control Policy has set 97 performance 
targets and 127 associated measures. Twelve of these performance targets have been designated as Impact 
Targets. They provide a report card for the effectiveness of  anti-drug programs. 
Five of those twelve performance targets relate to drug users and drug use:  e 
By 2002, reduce the nationwide prevalence of illegal drug use by 25 percent as compared to the 1996 
base year.  By 2007, reduce prevalence by 50 percent as compared to the base year. 
By 2002, reduce the prevalence of past month use of illegal drugs and alcohol among youth by 20 
percent as measured against the 1996 base year.  By 2007, reduce this prevalence by 50 percent as 
compared to the base year.  Reduce tobacco use by youth by 25 percent by 2002 and by 55 percent by 
2007. 
By 2002, increase the average age for first time drug use by 12 months from the average age of  first 
time use in 1996.  By 2007, increase the average age of first time drug use by 36 months from the 
1996 base year. 
By 2002, reduce the prevalence of drug use in the workplace by 25 percent as compared to the 1996 
base year.  By 2007, reduce this prevalence by 50 percent as compared to the base year. 
By 2002, reduce the number of chronic drug users by 20 percent as compared to the 1996 base year. 
By 2007,  reduce the number of chronic drug users by 50 percent as compared to the base year. 
I 
Five additional targets involve supply-side variables.  These targets are instrumental toward increasing the 
price of  illicit drugs, reducing the supply of illicit drugs, or both. They are important because reduced 
availability and higher prices should promote less drug use. 
By 2002, reduce drug availability in the United States by 25 percent as compared with the estimated 
1996 base year. By 2007, reduce illicit drug availability in the U.S. by 50 percent from the base year. 
By 2002, reduce the rate of outflow of illicit drugs from the source zone by 15 percent as compared to 
the 1996 base year.  By 2007, reduce the outflow rate by a total of 30 percent measured against the 
base year. 
By 2002, reduce the rate at which illegal drugs successfully enter the United States from the transit 
and arrival zones by 10 percent as compared to the 1996 base year. By 2007, reduce this rate by  20 
percent as measured against the base year 
Domestic production -  By 2002, reduce the production of methamphetamine and the cultivation of 
marijuana in the United States by at least 20 percent as compared to the 1996 base year and by 2007, 
reduce by 50 percent the production of methamphetamine and the cultivation of marijuana as 
compared to the base year. 
Domestic trafficker success -  By  2002, reduce by  10 percent the rate at which illicit drugs of U.S. 
venue reach the U.S.  consumer, as compared with the 1996 base year. By 2007, reduce this rate by 20 
percent over the base year 
The final two targets are consequences of reducing the number of drug users and the level of drug use. 
.  By 2002, reduce by  15 percent the rate of crime and violent acts associated with drug trafficking and 
use, as compared with the 1996 base year. By 2007, reduce drug-related crime and violence by 30 
percent as compared with the base year. 
By 2002, reduce health and social costs associated with illegal drugs by 10 percent, as expressed in 
constant dollars, as compared to the 1996 base year. By 2007, reduce such costs by 25 percent as 
compared to the base year. 
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programs will increase the price of illicit drugs and reduce their availability.  If this happens, then young 
children will have less access to illicit drugs: Fewer children will experiment with drugs, and whatever 
experimentation happens will occur at a later age.  Over time, fewer children will advance to occasional 
and chronic drug use.  Adults who would otherwise be drug users will reduce their use or stop altogether 
as drugs become harder to get, more expensive, and generally less appealing.  Workplace programs, and 
presumably other prevention programs (which do not have associated impact targets), are expected to 
reinforce the supply-side effect. Treatment, and presumably compulsion, will further reduce the number of 
chronic users.  I 
I 
Is this causal mechanism plausible? Can the Government appreciably increase the price of illicit drugs 
and otherwise decrease their availability? Will children, young adults, and other adults respond by 
reducing or stopping their drug use? Are the targets believable? This study intends to provide some 
answers. 
Methodology 
This study begins with interpretation of trends in the level of drug prices:  cocaine, heroin, 
methamphetamine and marijuana. Trends are taken from a report prepared by Abt Associates for the 
Office of National Drug Control Policy (Johnston, Rhodes, Carrigan and Moe, 1999). and interpretations 
are supported by additional studies done by Abt Associates for ONDCP.  However, the interpretations 
themselves are a product of this report. 
Using the drug prices, most of this report is focused on the demand for illicit drugs.  As pointed out by a 
recent panel of the National Academy of Sciences (Manski, Pepper and Thomas, 1999) ,  the demand for 
drugs does not take a single form. The National Drug Control Strategy recognizes this when it sets 
separate impact targets for children and for adults, and when it distinguishes chronic users from other 
users. Thus, this is not a study of the demand for drugs, but rather, a study of  the demands for drugs. 
It first investigates the initiation of drug use separately for marijuana, cocaine and heroin.  Data about 
initiation are not available for methamphetamine because data come from several administrations of the 
National Household Survey on Drug Abuse, and the survey did not ask the requisite questions about 
methamphetamine use.  We use a fixedeffects split-population survival model to analyze initiation rates. 
A methodological exposition appears later; here, we provide a summary. 
Byfued-eflects  we mean that the analysis always includes a variable that represents the place where the 
interview occurred. Initiation rates are likely to vary across the nation, and the fixedeffects control for 
that variation.  This also means  that all inferences are based on the covariation between drug prices and 
demand within a county.  None of the evidence comes from variation across places in the United States.' 
'  Reliance on cross-sectional  variation can be a specification error that leads to a biased estimate of how prices 
affect demand. Consider a simple, although contrived, illustration.  Because of Mormon customs, the use of 
intoxicants -  including illicit drugs -  is low in Salt Lake City.  The prices of drugs are relatively high in Salt 
Lake City, because drug markets are poorly developed and inefficient due to the lack of scale economies. In 
contras:,  drug markets are efficient in New York  City, so drug prices are comparatively low. The ethos in New 
York  City is supportive of illicit drug use, at least when compared with the ethical climate in Salt Lake City. 
Even if prices had no affect on consumption, cross-sectional variation would imply a strong price elasticity. The 
use of the fixed-effects prevents cross-sectional correlation from affecting the estimates. 
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event is the first time that the respondent tried a drug. The data were censored on  the right, meaning we 
could not observe use that happened after the survey. Survival models commonly deal with such 
censoring. 
By two-population we mean that, conceptually, the population could be divided into two parts.  The first 
part comprises people who will try a drug eventually given sufficient time.  The survival model only 
applies to them.  The second part comprises people who will not try the drug even if they were given an 
infinite length time to do so. The survival curve does not apply to them’ 
The fixedeffect two-population survival model is useful for the study of initiation, for two reasons. The 
first is that it represents a sensible way to think about how people initiate drug use. The second is that this 
model works well given the Strategy’s impact targets, expressed as the probability that people will ever try 
a drug and the age at which they start. 
i 
Second, this study investigates the current level of drug use by household members who have ever tried 
the drug. .For this purpose, we use a fixedeffects two-staged ordered probit model.  Analysis is limited to 
marijuana and cocaine because the NHSDA  has too little data about heroin and has not asked the requisite 
questions about kthamphetamine. 
As before,fixed-egecrs means that the analysis was conditioned on where a person lived at  the time that he 
answered the interview.  All inferences are based on the variation in drug prices within the place of 
residence over the period spanned by the interviews, 1988 through 1996. 
The basic model was an ordered probit model. The dependent variable fell into one of three  categories: (1) 
did not use during the year before the survey, (2) used less than weekly during the year before the survey, 
and (3) used at least weekly during the last year. The probit model is commonly used when a dependent 
variable takes ordered categories. The term rwo-staged means that the analysis was conditioned on the 
observation that the respondent had tried the drug some time in the past.  Conditioning was more than just 
limiting the analysis file to those who had tried drugs in the past.  The model recognized that the second 
stage decision (deciding whether or not to use currently and at what level), was stochastically dependent 
on the frst stage decision (electing to try a drug at some time), and the model takes that stochastic 
dependence into account. 
The two-staged ordered probit model affords an examination of drug use within the general population, 
which includes special groups, especially members of the workforce, targeted by the National Strategy for 
special attention. But the NHSDA  misses large numbers of hardcore drug users -  the chronic users 
identified by the impact targets. For them, we turned to a second data source, the Drug Use Forecasting 
data. 
To study drug use as reported in the DUF  data, we used a fixed-effects ordered logistic regression model. 
The use categories were:  (1) no use during the month before the interview, (2) use on 10 or fewer days 
during the month before the interview, and (3) use on 11 or more days during that month.  The ordered 
*  Of course, we cannot tell who belongs to the group who  will ever use drugs and who belongs to the group that 
will never use drugs.  We can only assess the probability of belonging to one group or the other, and that is done 
by statistical inference. 
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that fall into ordered categories. Preferences of two different analysts explain why we used a probit model 
in the first case and a logistic model in the second. 
Finally we used a simulation to project drug use into the year 2002  and 2007.  The simulation was based on 
trends observed in the analysis discussed above and varying assumptions about what would happen to drug 
prices between 1996 (the base year) and 2002  and 2007.  The years 2002  and 2007  were chosen because 
they are identified in the impact targets. 
Data 
The NHSDA  data is a national probability sample of household members.  (Recent administrations have 
expanded the survey to include people who live in group quarters, but this is a small sample and probably 
has little effect on any analysis.)  The survey has been administered every year since 1990. It was also 
administered in 1979, 1982, 1985, and 1988:  Given the relatively small samples and infrequent 
administration before 1988, we make most use of data from 1988 and later. 
The survey’s administration has changed over time.  Some questions have been added and some deleted. 
Questions about substance use have undergone subtle changes over time, but basically, the most important 
questions remained the same.  Nevertheless, we did a great deal of  data cleaning to assure data were 
consistent from year to year.  This means that response categories were collapsed to a lowest common 
denominator. For example, at one survey administration, a respondent might have been allowed to answer 
1,2 or 3 to a specific question. At another administration,  2  and 3 might have been collapsed into a single 
allowable category. We recoded the 2  and 3 response from the first survey into a single category. 
Appendix A provides a list of  variables used in the resulting analysis file. 
Somewhat different questions are asked about different drugs.  For example, there is more detail about 
marijuana use than about heroin.  Although some versions of the NHSDA have asked about expenditures, 
or amount used, we are skeptical of responses based on what we know about drug use from other sources. 
Regardless, those questions are not asked for all periods, so  we did not analyze expenditures for this study. 
The kinds of questions asked consistently are about lifetime use, yearly use, and monthly use. These are 
typically in the form:  Did you use the drug? How frequently? Elasticity estimates have to be based on 
such responses, so we seek to learn whether initiation of  drug use, participation in drug use, and frequency 
of  drug use vary with drug prices and other variables. 
The survey has a multi-stage complex sampling design, so inferences based on tabulations are not 
straightfoxward. Computation of standard errors for tabulations can be based on design-factor 
adjustments, or by  using special computing software, such as  SUDDAN. Although the point is arguable 
(see DuMouchel and Duncan, 1983; Deaton, 1997), regression-based studies can safely ignore the 
complex sampling design, provided covariates include stratification variables and the estimates are 
understood to be conditional on the sample, so regressions are based on unweighted data. We will take 
this approach because the use of special computing software was too limiting given that the complexity of 
our models necessitated, for the most part, the writing of our own computer code. 
The NHSDA is well-suited to the analysis contemplated here.  Its cluster sampling design selects some 
places with certainty, guaranteeing that those same places will be in the sample over time. This is 
’  We do not have the 1985 survey data. 
Abt Associates Inc.  Drug Demand and Supply  5 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not essential, because, as discussed, statistical inference is based on a time-series of usage patterns within an 
area. By using a fixed-effects design, we should be able to identify whether drug use changes with the 
price of illicit drugs and other factors. 
All regression results reported here used a fmed effects design, so it was important to have a suitable 
sample from each place for an extended period. We excluded places that had data for one or at most, a 
few years, which left us with 28 places consisting of 72,000  observations. We seldom used all data from 
these selected places.  Frequently we restricted the data by age group, and sometimes by gender and 
racdethnicity.  Because of concerns for confidentiality, the Office of Applied Studies requested that we 
not identify places selected for the study. 
I 
The NHSDA has major limitations. The survey seems  to miss many hardcore drug users, and those 
respondents who answer the survey often deny their drug use:  This does not seem like a crucial problem 
for a study of the demand for drugs provided the truthfulness of reporting is time-invariant, but time- 
invariance may be an unreasonable assumption. If  people are more willing to report drug use when drugs 
are more socially acceptable, then trends in reported drug use would be an unreliable measure of actual 
drug use.  We are unaware of anyone who has tested this assumption. 
The NHSDA seems to be the best source for studying the initiation of drug use, participation in drug use, 
and continuation of drug use, but the survey misses the heaviest or hardcore drug users. To study the drug 
use patterns of hardcore drug users, we used the Drug Use Forecasting/Arrestee Drug Abuse Monitoring 
‘  Evidence that a large segment of the drug-using population is excluded from the NHSDA comes from a number 
of sources.  According to the 1991 NHSDA, drug use is twice as high among respondents who lived in 
households considered unstable than it is among those who lived in more stable environments, indicating the 
NHSDA’s bias toward reporting on stable households is likely to miss many heavy drug users.  Additional 
evidence also comes from interviews with nearly 35,000  intravenous drug users who were contacted by National 
Institute on Drug Abuse-sponsored researchers as part of an AIDS  outreach project.  Abt Associates’ tabulations 
show that of these drug users, an estimated 40  percent lived in unstable households and about 10 percent could 
be considered homeless. 
Available evidence indicates that NHSDA’s respondents understate heavy drug use.  A. Harrell, K.  Kapsak, I. 
Cisin, and P. Wirtz, “The Validity of Self-Reported Drug Use Data: The Accuracy of Responses on Confidential 
Self-Administered  Answer Sheets,” paper prepared for the National Institute on Drug Abuse, Contract Number 
271-85-8305, December 1986.  M. Fendrich, T. Johnson, S. Sudman, J. Wislar and V. Spiehler, ‘‘ Validity of 
Drug Use Reporting in a High-Risk Community Sample: A Comparison of Cocaine and Heroin Survey Reports 
with Hair Tests,” American Journal of  Epidemiology  149(10): 955:62,1999.  Consistent with these observations, 
the Substance Abuse Mental Health and Services Administration reports that virtually no heroin addicts answer 
the National Household Survey on Drug Abuse.  Substance Abuse Mental Health and Services Administration, 
Preliminary Estimatesfiom the 1993 Household Survey on Drug Abuse (lune 1994). 
A comparison of the demographic characteristics of the heavy cocaine users in the NHSDA with those of heavy 
cocaine users based on other sources (the Drug Use Forecasting program, the Drug Abuse Warning Network, 
and the National AIDS Demonstration Research project) shows a marked difference in populations in the 
NHSDA population. Incomes are greater, unemployment is lower, and there are fewer respondents using more 
than one drug.  D. Hunt and W.  Rhodes, “Characteristics of Heavy Cocaine Users Including Polydrug Use, 
Criminal Behavior, and Health Risks,” paper prepared for Ofice of National Drug control policy (ONDCP), 
December 14,1992. 
Finally, estimates of heavy drug use reported in the NHSDA are difficult to reconcile with other data sources 
maintained by the Substance Abuse Mental Health Services Administration, especially with reports of the 
treatment for cocaine or heroin.  These incompatibilities are discussed later in this report. 
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had not changed over time, the fact that it is a non-probability sample would have little significance, 
because elasticity estimates could be conditional on whatever sampling had been in place. A different 
problem arises, however, when the sampling plan changes over time, because we would not be able to 
distinguish between changes in drug use and coincident changes in arrestees who are sampled. 
Unfortunately, we were unable to identify when sampling procedures changed in each of the DUF site 
samples, so estimation had to proceed as if those changes were insignificant. The DUF data provide 
self-reports of frequency of use for drugs of principal interest to us.  Arrestees often refuse to report 
their drug use, especially their most recent drug use.  Our analysis is based on the truth tellers, that is, 
those people who are willing to report how recently and how frequently they have used drugs.  Of 
13,759  arrestees  who tested positive for opiates, 8,342  said they had used heroin during the 30 days 
before the interview?  This implies a truthful reporting rate of about 0.61 for heroin users.  Of  73,504 
arrestees who tested positive for cocaine, 4  1,346  said they had used cocaine or crack during the 30 
days prior to the interview. This suggests a truthful reporting rate of 0.56. 
This  approach-restricting data to truth tellers-should  have no important bias provided truthfulness 
rates have remained constant over time.  To our knowledge, NU  has not tested this important 
assumption. We have conducted some informal inspection tests by graphing truthfulness rates (based 
on urine tests) as a function of time.  Excluding the first year of DUF  program operation, truthful 
reporting has not changed much over time.  Consequently, restricting the analysis to truth tellers is 
probably innocuous. 
These estimates of the rate of truthful reporting seem too low.  There are two problems.  The first 
problem is that the urine tests have a small but appreciable false positive rate.  As  an  illustration, we 
observe that DUF sites with a low prevalence of heroin use (based  on urine testing) have a lower than 
average rate of admissions of use (based on the above criterion). 
'  Someone who tested positive for opiates must have used an opiate within about three days of their 
interview. This  three-day period is included within the last thirty days, so anyone who tested positive 
would be lying if he said he had not used in the last thirty days. Of course, people could have used in 
the last thirty days and still tested negative at the time of the interview, but that fact is irrelevant to a 
judgement about the rate of truth telling. 
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Proportion of Arrestees Admitting Use as a Function of the Number Who Tested Positive 
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The pattern is clear:  The larger the number of arrestees who tested positive for heroin, the larger the 
proportion of those who tested positive who also admitted recent use.  The interpretation is less clear. 
Certainly we would expect false positive rates on the urine screen to be larger when the prevalence of 
heroin use is relatively low.  Consistent with this explanation, 7  percent of arrestees who test positive 
for opiates in Omaha (only 116 positive urine tests) admitted 3May  use of heroin and 18 percent of 
those who tested positive in Fort Lauderdale (only 130 positive urine tests) admitted 3O-day use.  In 
contrast, we see reporting rates of  71 percent in New York (1493 positive urine tests) and 65 percent 
in San Diego (1069 positive urine tests).  This same problem with truthfuI reporting does not seem to 
affect cocaine, whose prevalence is fairly high everywhere. 
A second problem was suggested by the ADAM  program. The DUF  survey is being replaced by the 
Arrestee Drug  Abuse Monitoring (ADAM) survey. When pretesting the ADAM  instrument, the 
ADAM  team found that many people who tested positive for a drug denied use during the last three 
days but admitted use during 27 or 28 days during the last month.  Apparently they simply wanted to 
avoid an admission of the drug use episode most associated with their arrest, but they were willing to 
report about other use.  This phenomena would cause hardcore drug users to be more truthful than 
occasional drug users, so estimates of truthfulness may be understated for hardcore users. 
At any rate, the rate of truthful reporting for heroin use would seem to be higher than 61 percent, and 
the rate for cocaine use would seem to be higher than 0.56, but we are uncertain how much higher. 
Another way to look at these data is to ask:  Of those people who tested positive for opiates, what 
percentage of them were willing to admit to illicit use of any  drug during the month before the survey. 
Unless there is some reason to expect people to deny heroin use but admit other use, this percentage 
would seem to be a reasonable measure of being truthful. For this purpose, we excluded marijuana, 
because its use is less stigmatized or possession laws are not enforced in many places, so there is less 
reason to deny its use.  Of those who tested positive for opiates, 73 percent were willing to admit 
some illicit drug use other than marijuana.  For those who tested positive for cocaine, 61 percent 
reported that they used some illicit drug other than marijuana during the month.  Given this alternative  a 
i 
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This analysis relied on answers to the question about the number of days durinF the last month that 
the respondent used a specified drug.  We have worked in other contexts with a separate question 
about expenditures on drug use, and we know that interpreting answers to this question poses some 
problems:  The question lumps together all drugs, so it is impossible in many cases to identify 
expenditures on specific drugs.6 Another problem is that the responses to this question are highly 
skewed and the extreme values lack credibility. Consequently, our analysis was based on responses 
to the frequency question. 
These problems aside, the DUF data were very useful for our analysis. DUF  provides a lengthy time- 
series of reported drug use by a population that is at an especially high risk of heavy substance abuse. 
Again, the analysis is based on a fixedeffect model, so a lengthy time-series over a suitable cross- 
section of data was crucial. 
Table 1, which outlines the number of  DUF interviews by year by site,  is deceptive about the size of 
the sample for parts of this analysis. To be included into this study, a place had to have a credible 
price-series estimate. This was always the case for cocaine use, so most of these DUF data entered 
into our analysis of the demand for cocaine. That was the case for methamphetamine prices in only 
five places.  This is not as limiting as it might seem, however, because these five were the only DUF 
sites for which arrestees reported an appreciable amount of methamphetamine use.  Inclusion of other 
sites would not have told us much. 
Of course, the above analysis assumes that we have credible price series for the cost of  illicit drugs. 
Abt Associates staff have developed price series for cocaine, heroin, marijuana and 
methamphetamine. These estimates provide a good basis for supporting this analysis. They are 
discussed later in this report. 
Data on the price of alcohol were taken from the Consumer Price Index for all Urban Consumers 
(CPI-U) published monthly by the Bureau of Labor Statistics. The Bureau of Labor Statistics defines 
the Consumer Price Index as "a measure of the average change in prices over time in a fixed market 
basket of  goods and services" (U.S.  Department of Labor 1992).  The Bureau of Labor Statistics 
includes beer, wine and distilled spirits, consumed both "at home and away," in the "alcoholic 
beverages" category.  Data are collected in 85 urban areas, from about 57,000 households and 19,000 
retail establishments (U.S.  Department of  Labor 1992).  Bureau of Labor Statistics researchers visit 
stores to assess prices monthly or bimonthly, depending on the location and the item to be priced. 
Important for our purposes, the Consumer Price Index includes taxes in the price, and changes in tax 
rates account for sharp changes in alcohol prices. 
Many users receive their drugs as gifts, for example from a partner, or as  income in kind, for example as 
payment for serving as a dealer's lookout.  Similarly, expenditure can include expenditures for the 
consumption of others, including the customers of dealers.  The  andysis will need to take these issues into 
account, perhaps by  eliminating outliers that would seem to be associated with the above phenomena. 
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approach of Rydell and Everingham (1994).  Caulkins and Reuter (1997). and our own work to 
construct a supply curve from its component parts.  e 
To explain, the price that drug dealers charge their clients must cover the costs of selling drugs.  As 
economists use the term, or at least as we are using the term here, costs include factor costs such as 
labor, capital and raw materials and also what might be seen as profit.  In the drug world, apparent 
profits actually cover the special costs of doing business, including the costs associated with the risk 
of law enforcement, the costs associated with a physically dangerous working environment, and the 
risk of operating in settings where contract law is unavailable for settling disputes. 
Being precise about the cost components is beside the point. The important issue here is to learn how 
street-prices change with public interventions intended to restrict drug supply and increase the costs 
of dealing. For close to a decade, Abt researchers have been working with ONDCP  to develop flow 
models for illicit drugs (Layne, Rhodes and Johnston, 1999; Rhodes, Layne and Johnston, 1999).  At 
this time, we have credible flow models for cocaine and heroin, and a nascent model for marijuana. 
ONDCP has recently asked us  to work with National intelligence agencies to develop models that will 
become  the Government’s official estimates. The data used for supply-based elasticity estimates 
come partly from that assignment. 
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This Chapter provides a brief literature review in three areas:  Estimates of the demand for illicit 
drugs, estimates of  the supply for illicit drugs, and estimates of the price of  illicit drugs. 
The Demand for Illicit Drugs: Literature Review 
Price elasticity of demand for illicit drugs is the percentage change in demand for illicit drugs per 
percentage change in price of illicit drugs.  There are few direct empirical studies on the price 
elasticity of demand for cocaine, marijuana, heroin, and other illicit drugs. Nisbet and Vakil (1972) 
provided an early estimate of price elasticity of demand for marijuana. Their data on both the quantity 
purchased monthly and the purchasing price were from an anonymous mail survey of UCLA students. 
Conditional on purchasing, their estimate was in the range from -0.37 to -1.5  1, depending on 
whether the regression’s functional form was double-log or linear. 
Several authors have estimated price elasticities using national survey data.  Based on pooled data 
from the 1988,1990 and 1991 NHSDA surveys and Drug Enforcement Administration’s STRIDE 
price data, Saffer and Chaloupka (1995) found that the annual  participation price elasticities for 
heroin and cocahe are -0.90 and -0.55, respectively, and monthly participation price elasticities are 
-0.80  and -0.36, respectively. Assuming that the use price elasticity conditional on  participation is 
about the same size as the participation price elasticity, they claimed that heroin’s price elasticity is 
about -1.80  to -1.60  and cocaine’s is about -1.10  to -0.72:  Based on data from the Monitoring the 
Future (MFT) surveys, Chaloupka, Grossman, and Tam  (1996) estimated both the participation 
price elasticity and the use elasticity conditional on participation, separately, using Cragg’s two-pat 
regression models. Their results showed that for annual data, the participation and use price 
elasticities are -0.89 and -0.40,  respectively; for monthly data, they are -0.98 and -0.45, 
respectively. 
e 
Critics argue that national survey data fail to represent hardcore drug consumption, so Caulkins 
(1995) based his estimates on data from DW.  After making specific assumptions on the relationship 
between drug use and the probability of arrest, and by using the percentage of arrestees testing 
positive for cocaine and heroin as a proxy for drug use, he estimated that the price elasticity of 
demand for illicit drugs is large: -2.50 for cocaine and -1 SO  for heroin. 
The above studies did not use the recent development of economic theory on addictive behavior. 
According to Becker and Murphy (1988), an economic model based on rational choice predicts that 
drug consumption is negatively correlated with past, current, and future prices; that current drug 
consumption is positively correlated with past and future consumption; and that the long-run price 
elasticity is greater than the short-run elasticity. Grossman, Chaloupka, and Brown (1996) applied 
this theory to the demand for cocaine by young adults in the MTF panel.  Their findings were 
’  They also estimated that marijuana decriminalization increased the probability of marijuana participation 
by about 4 to 6 percent. 
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elasticity of demand for cocaine is -1.18  and the short-run unconditional price elasticity is -0.7 1. 
The above studies are direct estimates of demand elasticity, but the effects of qrices on illicit drug 
consumption can also be studied indirectly.  For example, Silverman and Spruill(l977) found that 
property crimes were positively correlated with, but other crimes were independent of, the price of 
heroin. This suggested an inelastic demand for heroin.  Rhodes (1996) found that decreases in heroin 
prices are weakly linked to an increased number of heroin addicts appearing in jails and lockups. 
Hyatt and Rhodes (1995) reported a significant negative relationship between the estimated street 
price per gram of cocaine and the level of cocaine-related medical emergencies and  deaths, as well as 
the number of arrestees who test positive for cocaine, suggesting that cocaine consumption is 
sensitive to its price. This kind of inference, nonetheless, does not provide an estimate of price 
elasticity. 
Studies on price elasticity of demand for other addictive goods such as alcohol and cigarette can also 
shed some light on the price elasticity of demand for illicit drugs.  For instance, using disaggregated 
data,  Chaloupka (199 1) found a short-run price elasticity of demand for cigarettes at -0.20 and long- 
run elasticity at -0.45. Using state-aggregated data, Becker, Grossman, and Murphy (1994) found a 
short-run price elasticity of demand for cigarettes at -0.44 and long-run elasticity at -0.78.  For 
alcohol, Manning and Mullahy (1997) estimated that the price elasticity of any drinking is -0.37, that 
for frequency if a current drinker is -0.34,  that for quantity per  drinking day is 4.09,  and that the 
overall unconditional frequency of drinking is -0.70.  Applying the rational addiction model, 
Grossman, Chaloupka, and Sirtalan (1998) estimated that the long-run price elasticity of  demand for 
alcohol ranges from -0.26 to -1.26,  and the short-run price elasticity ranges from -0.18  and -0.86. 
The ratio of the long-run elasticity to the corresponding  short-run elasticity varies from 1.44 to 1.77. 
In summary, the literature suggests that the price elasticity of demand for illicit drugs is large 
(perhaps around -I)  and that the long-run elasticity is larger than the short-run elasticity. The 
existing studies, however, suffer from several problems. 
As mentioned earlier, the NHSDA and MTF surveys probably miss most hardcore drug users, but 
those surveys provide the best available data about the initiation of and continuation of drug use by 
members of the general population.  Consequently, many researchers have used the NHSDA  and 
MTF to study the demand for cigarettes, alcohol, and  illicit drugs within the general population. 
When used this way, the survey data suffer from a serious problem:  the surveys have identified the 
respondent’s State (e.g., California) but not the respondent’s specific location (e.g.,  San Francisco) 
within that State. Consequently, when estimating price elasticity, these researchers have had to use a 
State-average  price despite the fact that drug prices seem to vary widely from city to city. This 
measurement error will bias parameter estimates. Our study deals with that problem by using the 
NHSDA’s places. 
Another problem is that there are few studies about the cross elasticity of demand for illicit 
substances (for an exception, see  Caulkins, 1995) and apparently there are no studies of the cross 
elasticity of demand for alcohol and illicit drugs. This latter omission is especially important when 
considering drug use by youths, for whom alcohol is an illicit substance, and for whom single drug 
consumer behavior is rarely established. The NHSDA and DUFIADAM data allow us to compute 
cross elasticity estimates for the following drugs: cocaine, heroin, marijuana, methamphetamine, and 
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focus on youths, because the survey over-samples children age twelve and older. 
We also question the statistical methodology used in some  of these studies, although we should be 
clear that the methodology might have been appropriate for the more limited data available to earlier 
researchers.  Most researchers have used a two-part model, which assumes that the decision to use 
drugs  is independent (in some  regards) of the decision about how much to use.  The limitations to a 
two-part model are familiar to quantitative criminologists, who recognize the problem as that of 
selection bias. 
The Supply of  Illicit Drugs:  Literature Review 
Reuter’s seminal work on drug supply (for example, Reuter, Crawford and Cave, 1988)  challenged 
the effectiveness of source country and interdiction activities. This case has been reinforced by Rydell 
and Everingham (1994). In brief, these arguments rest on one key observation and one basic 
assumption. The observation is that the costs of producing and transporting cocaine to the United 
States and across its borders is a small fraction of the retail price of cocaine. The assumption is that 
the price markup from the U.S.  border to U.S.  city streets is additive. That is, the retail price PR  is a 
linear function of the price at the border PB  and a markup:  MI,  so: 
Thus, even if source country and interdiction programs are effective at (say) doubling the cost of 
cocaine at American borders, the effect on street prices will be minimal because M1 is large relative to  e  PB. 
Others (for example:  Crane, Rivolo and Comfort, 1997)  have challenged this conclusion, finding to 
the contrary, that source country programs have had a signifcant effect on street prices for cocaine. 
They argue that street prices are a multiple of prices at the border.  That is, the retail price is a 
multiplicative function of the border price, so: 
While they do not necessarily agree with Crane and his colleagues, others (Caulkins and Padman, 
1993;  Rhodes,  Hyatt and Scheiman, 1994;  DeSimone, 1998)  present evidence that is consistent with 
the multiplicative model, thereby adding support to Crane’s position. 
Recent discussions at a National Research Council workshop (Manski, Pepper and Thomas, 1999) 
seem to suggest that neither the Rydell and Everingham nor the Crane, Rivolo and Comfort positions 
are convincing.  There is much to learn about the costs of producing, transshipping and distributing 
illicit drugs. There exists a need to better understand how drug prices are marked-up from the border 
to the street. 
Researchers have made remarkable progress during the last decade at developing price series for 
illicit drugs.  Notable is the work of Caulkins and Padman (1993)  and several other papers by 
Caulkins and his colleagues, as  well as the work of Rhodes, Hyatt and Scheiman (1994)  and several 
other papers by Rhodes and his colleagues, including Johnston, Rhodes, Carrigan and Moe (1999). 
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the lower distribution levels and multiplicative at the higher distribution levels.  In effect, the retail 
price is a mixture of multiplicative and additive elements, best written as: 
The question, then, is the relative size of MI  and Mz.  We use the results from the Johnston, Rhodes, 
Carrigan and Moe study below. 
The Interaction between Supply and Demand 
Estimating a demand curve places subtle but important demands on the analysts.  Over time we can 
observe that drug purchases increase or decrease as  drug prices decrease and increase. We  might be 
inclined to infer that the size of the decrease in drug use that results from an increase in drug prices is 
a measure of buyer's responses to higher prices.  Unfortunately, this inference may be  very wrong, 
and certainly it does not hold unless we are willing to make additional assumptions. Econometricians 
call this the identification problem. But rather than provide a technical exegesis, which can be found 
in any econometrics textbook discussion of the estimation of  simultaneous equations, a more intuitive 
interpretation may prove more useful. 
A demand curve is a function that relates the amount of a good -  such as cocaine -  that consumers are 
willing to buy at various prices.  A supply curve is a separate function that relates the amount of a 
good -  cocaine again -  that suppliers are willing to provide at different prices.  An equilibrium is 
established at the unique price at which the amount that consumers want is the amount that suppliers 
are willing to sell.  If  the price were too low, then buyers would want more than suppliers would be 
willing to supply. Those consumers who were willing to pay more would bid the price upward.  If the 
price were too high, then buyers would want less than the suppliers offered. To get rid of their stock, 
supplier would lower their price. 
We assume that the supply of  cocaine is highly elastic.  This  means that suppliers will provide about as 
much cocaine at a set price as consumers are willing to buy at that price.  Cocaine is inexpensive to 
produce.  It is basically an agricultural product that requires minimal inexpensive chemical 
processing.  The product is fairly easy to transport, and only about 300 metric tons satisfies the entire 
U.S.  domestic market.  Apparently the largest cost involved in transporting cocaine is reimbursement 
for the risk of transporting and distributing it.  Some of these risks are imposed by the industry itself, 
which has to rely on violence in the absence of legitimate contracting vehicles.  Other risks result 
from interdiction and law enforcement, activities that force dealers to contend with substantial prison 
terms and loss of  assets when caught.  Over the long run:  suppliers can increase the amount of  ' 
cocaine without substantially changing the above costs, so the supply curve seems  quite elastic. 
A major expansion in product would require an  increase in cultivation.  Coca is grown in regions that are 
unsuitable for all but a few other agricultural products.  Fields can be brought into cultivation by burning 
rain forests.  Crops can be harvested in one to two years, depending on the strain of cocaine.  Moreover, it 
appears that the amount of coca harvested exceeds the amount shipped by a substantial amount. 
Presumably, suppliers can draw on that extra harvest to satisfy an expanding market.  It would appear that 
suppliers could expand their product without increasing its per unit cost. 
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as the supply curve -  and hence drug prices -  increased and decreased over time.  But suppose that 
the demand curve itself changed so that consumers would demand more or less of a drug at the same 
price. Depending on the exact shape of the supply curve, we would see a price change and also a 
change in consumption. For example, if the supply curve sloped upwards, then price would increase 
while the amount purchased would decrease. Or, if the supply curve were perfectly flat, then the 
price would remain the same while consumption fell.  Either way, the change in consumption that 
accompanies the change in price would not reflect how consumers respond to price!  If we allowed it, 
the shift in the demand curve would fool us into thinking that we had measured price elasticity when 
in fact we had measured something entirely different. 
To estimate the elasticity of  demand we have to hold the demand curve constant and allow the supply 
curve to shift. This demanding requirement is difficult to satisfy.  We try to hold the demand curve 
constant statistically by introducing covariates into the analysis. This is not particularly satisfying 
because the data are not rich in covariates and, furthermore, important variables such as social 
acceptability of drug use and perceptions of the danger of drug use are not observable, yet these seem 
to change over time? 
We cannot altogether solve this problem.  It is probably not a serious problem for hardcore drug 
users, because their numbers have not decreased much over time.  That is, we suspect there have been 
no large shifts in demand by hardcore users. It is a more serious problem for casual users because, 
over the period studied here, the demand curve seems  to have shifted substantially. The only way we 
have to deal with this problem is to introduce age cohorts as control variables.  For reasons explained 
subsequently, this is not a very satisfactory solution. 
Limitations of this Study 
Several problems arise when estimating demand elasticity for illicit drugs.  We have already 
discussed the “identification problem**  above.  Some other problems are conceptual, and still others 
stem from data limitations.  We discuss those problems here. 
Cocaine and heroin are exchanged at nominal prices that vary little if at all over time.  For example, 
five years ago a New York addict might have bought a nickel ($5), dime ($10) or quarter ($25) bag of 
heroin.  He could buy at the same nominal prices today. The difference is that nickel/dime/quarter 
bags contain more heroin today than they contained five years earlier. 
Recognizing that nominal prices are invariant, we represent prices in standardized units, computed by 
dividing the nominal price by the pure amount of drug in the purchase.  Although this way of 
representing prices imparts variation to the price data, we are uncertain about how consumers respond 
to price changes that really reflect variation in the quality of the product, not its price.  Clearly 
consumers must be sensitive to quality issues, because otherwise dealers would always seek  to 
provide a low quality product. Also, consumers who are habituated physically will not readily 
Even if they were observable, there are questions of simultaneity. Does a negative attitude, as  expressed on 
a survey, cause a person to avoid drug use? Or do drug users tend to have positive attitudes toward using 
drugs? 
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Variation in the quality of drugs sold on the street is already so  great that distinguishing a change in 
mean price from random variation must be difficult. The way that drugs are transacted, then, may 
imposed special problems when we try to identify demand elasticity. 
A second problem is that drug prices have not changed in ways that would be desirable for estimating 
elasticity. Cocaine and heroin prices both declined sharply until about 1988, and since then, the 
decline has been gradual.  Because this change in prices has been basically monotonic, estimation has 
a difficult time distinguishing price effects from secular trends in drug use. 
Still a third problem is that price estimates are subject to significant measurement error.  The 
estimates are good enough to detect trends, but short-term variation is uncertain. This is unfortunate, 
because short-term variation is essential for detecting price elasticity given that long-term trends are 
monotonic.  Additionally, random variation in the price variable imparts a downward bias to the 
parameter estimate of greatest interest to us, namely, the effect that price has on demand. 
i 
These problems are worse for some drugs than for others.  Unlike the nominal price for heroin and 
cocaine, the nominal price of marijuana does change.  Furthermore, marijuana prices increased from 
the early 1980s &to the early 1990s and then declined, as domestic growers replaced many foreign 
providers.  This increase, followed by a decrease, portends greater promise for distinguishing  price 
responsiveness from secular trends.  On  the other hand, marijuana price estimates have less precision 
than their heroin and cocaine counterparts, which partly offsets the advantages that otherwise accrue 
when estimating consumer responses to marijuana prices. 
Another problem when studying the demand for drugs is that, while the market price is observable, 
another aspect of price is not observable -  namely, the risk of being a purchaser.  This  risk varies with 
the level of law enforcement and the consequences of being caught and punished. 
Still another problem is that people do not report exactly what we would like to know about their 
consumption.  They tell us the frequency of use expressed in days per stipulated period. They do not 
tell us how much they used during a day, and conceivably a users might react to prices by reducing 
daily use  but not the number of days during which he uses.  Or, he may use smaller quantities per use 
episode.  This would certainly be the case if users reacted only to nominal price, because then they 
would use just as frequently but at lower dosage units. 
A final problem, at least in this discussion, is that the apparent relationship between price and demand 
may be just a reflection of market disequilibrium. A short-run shortage in cocaine, for example, will 
necessitate that people use less.  If prices have sufficient  time to adjust, then consumption decisions 
will reflect the demand curve.  But prices may not reach a new equilibrium, so that the quantity 
purchased is not the amount that users choose to buy at a prevailing price, but rather the amount that 
is forced upon them. 
These are serious problems, but they do not mean that we cannot develop meaningful measures of 
consumers’ responsiveness to drug prices.  We can observe variation in usage patterns, even if the 
ways that people report their use is not exactly what we want to know.  We can observe trends and 
short-term variation is drug prices, even if those price estimates have less temporal variation, and 
more measurement error than we would like.  Identification is a problem, not easily solved, but we 
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greatest effect on prices, so while estimates of  a negative correlation between prices and drug use are 
subject to interpretation, we feel confident that the parsimonious explanation is that higher prices 
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Chapter 3  The Supply of Illicit Drugs to the 
United States 
Americans use roughly 300  metric tons of  cocaine and 12 to 13 metric tons of heroin every year 
(Layne, Rhodes and Johnston, 1999; Rhodes, Layne and Johnston, 1999).  We know a great deal 
about the origins of those drugs and how they get into the United States. Americans use over 100 
metric tons of marijuana every year and another 10 to 12 metric tons of methamphetamine. We know 
less about the origin (much of which is domestic) of  these drugs and how they get into the United 
States. Most of the detail about those drug flows is of marginal interest to this study, but we are most 
interested in one aspect of those flows -  how they determine prices paid in the United States for illicit 
drugs. Specifically, how are those prices affected by Federal, State and local antidrug programs? 
Our assumption is that those programs work by making drugs more expensive than they would be 
otherwise, so that observed prices are a reflection of  the cost of  doing business. Of course, this is at 
best an approximation. Prices are affected by demand as weli as by supply.  However, since the late 
1980s. the number of heavy drugs users has not changed much in the United States, and the number 
of people who use drugs at more moderate levels has not changed much since about 1990 (Rhodes, 
Layne, Johnston, Hozik, 1999).  We therefore doubt that much of the change in drug prices has been 
demand driven.  Instead, changes in drug prices seem to have resulted from systemic changes in drug 
marketing that have nothing to do with counter-narcotic efforts.  For example, the large drops in 
cocaine prices from the early to the late 1980s may have resulted from dramatic changes in how 
cocaine was traffkked to the United States and how it was marketed (as crack) on American streets. 
As  another example, the continued fall in heroin prices, and the emergence of high purity heroin sold 
at retail, was coincident with a growing dominance of South American suppliers of heroin (Rhodes, 
Layne, and Johnston, 1999; Rhodes, Truitt, Kling and Nelson, 1998).  One cannot say that these 
changes were necessarily independent of law enforcement efforts.  For example, focused attention on 
Southwest and Southeast heroin dealers may have created an environment conducive to Colombian 
heroin producers. Thus, cocaine and drug prices seem to have changed for reasons that have nothing 
to do with a shift in demand. 
0 
. 
The Price of Illicit Drugs 
Any study of the elasticity of demand for illicit drugs necessarily rests on estimates of the market 
prices of those illicit drugs.  Market prices are different to estimate and estimates are uncertain 
(Manski, Pepper and Petrie, 2001).  Thus study uses estimates provided by Abt Associates Inc. to the 
Office of National Drug Control Policy. The limited scope of this present study precludes our 
providing a detailed methodological explanation here.  We refer interested readers to Johnston, 
Rhodes and Kling, 2001.  A summary appears below. 
e 
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Figure 2 represents the estimated price of cocaine across several hypothetical distribution levels. 
Those levels are hypothetical because neither cocaine nor any other illicit substance is traded across 
clearly demarked distribution levels, but these hypothetical distinctions are nevertheless useful when 
telling a story about cocaine prices. The curve shows border prices, expressed as 1998 equivalent 
price per pure gram.  In the late 199Os, cocaine at the border sold for under $25,000 per pure 
kilogram,  and given that cocaine is imported at about 85 percent punty, this represents a price of 
about $20,000 per  bulk kilogram. These estimates may be a few thousand dollars higher than actual 
border prices (see Johnston, Rhodes, Carrigan and Moe, 1999). but their accuracy is sufficient for 
present purposes.  I 
Cocaine is much more expensive when bought by final consumers -  roughly about $175 per pure 
gram ($200,000 per kilogram). When sold at retail, cocaine is about 75 percent pure, on average, so 
the price per bulk gram is closer to about $130 per gram.  Price and purity vary widely from purchase 
to purchase and from purchaser to purchaser, so  the $130 should be seen as a rough measure of a 
typical price. 
Cocaine is basically an agricultural product that requires minimal and inexpensive chemical 
processing to convert coca leaves into paste, base  and HCI. It does not perish easily, and about 300 
metric tons satisfies current consumption in the United States, so absent law enforcement cocaine 
might have a price similar to aspirin.  Source country and other interdiction programs, and other 
forms of law enforcement, must account for most of  the $25,000 border price. In this regard, law 
enforcement has been a resounding success at reducing the supply of cocaine to the United States. 
A glance at Figure 2 shows that the price of cocaine fell sharply from the early to the late 1980s. 
Thereafter, prices declined less sharply, and much of the post 1988 decline resulted from an increase 
in the consumer price index.  We might date the inauguration of the current war on drugs with late 
1987 implementation of the Anti-Drug Abuse Act of  1986. which greatly increased mandatory 
minimum terms for drug trafficking, and with the concomitant increase in drug-law prosecutions by 
the Reagan Administration. Figure 2 implies that implementation of  the war on drugs had a 
meritorious effect on halting cocaine’s price slide. 
After 1988, expenditure on law enforcement continued to increase, but those expenditures may have 
entered a period of diminishing returns, during which additional expenditures proved unable to 
reverse the decline in cocaine prices.  Inferences are uncertain, because other factors played a role. 
The number of Americans who used cocaine declined starting in 1988 as increasing numbers of 
Americans recognized the dangers of cocaine use and as  an increasing number of heavy  users entered 
prison.  Decreased demand probably worked to further reduce prices that, otherwise, might have 
increased as law enforcement expanded. Furthermore, cocaine producers and shippers constantly 
adapt to law enforcement efforts, as shown by recent shifts in cultivation from Peru to Colombia (as 
base shipment from Peru to Colombia became increasing uncertain), and by temporal shifts from air 
and maritime to transshipment across the Southwest Border.  We cannot know for certain how lower 
levels of law enforcement would have affected cocaine prices. 
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Estimated Cocaine Prices at Five Levels of Distribution 
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Regardless of what we conclude about the long-run effectiveness of  interdiction, there are short-term 
success stories. Figure 2 shows several spikes in cocaine prices.  Some  of these are random 
fluctuations, but others seem real because spikes in border prices cascade throughout the distribution 
chain. Because each of the curves represented in Figure 2 was estimated independently of each of the 
others, there seems to be no reason to explain this cascading effect except by attributing it to 
interdiction. (For a more rigorous analysis that supports this presumption, see Layne, Bruen, 
Johnston and Rhodes, 2000.)  This evidence points toward the short-term success of interdiction 
programs that, unfortunately, have typically lasted about three months. There is less evidence of a 
sustained impact of marginal increases in interdiction resources. 
Note that cocaine's street price is much higher than its border price. The cost of distributing cocaine 
to final users would seem to be an insignificant proportion of the street price in a legal marketplace, 
so most of the difference between the border price and the street price must result from cocaine's 
being illegal.  Because cocaine is illegal, the law provides no recourse to enforcing contracts, leading 
to extra-legal means including violence.  Substituting violence for legal contracts increases the cost of 
doing business because dealers have to be compensated for the risk of physical harm and death.  In 
this regard, the law is passive, reducing drug trafficking by failing to recognize it as legal economic 
intercourse. Law enforcement increases the price of cocaine in another, more obvious way, by 
imposing risks of those who produce and sell the product.  But while expenditure on law enforcement  e 
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selling cocaine -  has remained remarkably resilient. 
The cost of doing business domestically is estimated by the distance between the curve represe’nting 
retail level price and the curve representing border price.  Earlier we reported that the street price was 
determined by a formula: 
We can estimate the parameters of this regression using the border price and street price reported in 
Figure 2.  Table 2 summarizes results for this and two other related models. 
Regresslon Results:  Relationship between Street Prices and Border Prices for Cocaine 
variabla  L8tbtO  t  -vrlua  L8t-t.  t-mlUO  L8t-t.  t  -valua  ................................................................................... 
CONSTANT  123.582605  17.730255  232.850626  13.401628  355.770279  10.404359 
BORDER  2.247582  16.265400  1.271089  7.029982  1.009375  4.874395 
Tm  -110.817641  -6.595377 
TmA0.4  223.302587  -6.868248 
R-SQUARE  0.823  0.901  0.908 
This model fits the data reasonably well (R2  3.82)  and implies that the additive markup is about 
$124 per pure gram and the multiplicative markup is about 2.24, meaning that a price of $25 at the 
border increases street prices by $25~2.24.  A second model allows the additive markup to vary 
linearly over time, with the result that the additive markup averages about $175 per pure gram and the 
multiplicative markup is about 1.27, meaning that a border price of $25 increases the street price by 
$25* 1.27.  A third model gives the “best fit” of these data. To get it, we raise time to the power 0.4, 
and then estimate the regression.  This implies that the current additive markup is about $130 and that 
the multiplicative markup is very close to one. 
Not all these inferences can be true.  Either the border price markup is large - 2.24 - or it is small - 
1.01; but it cannot be both.  Unfortunately, we cannot tell from these data, because inferences are very 
sensitive to how we model the relationship. 
Certainly there are some models that show an appreciable multiplicative markup, implying that 
source country and interdiction programs can be effective at increasing street prices provided those 
programs can increase the border price.  Because border prices are so high, relative to the underlying 
cost of marketing and exporting cocaine, source country and interdiction programs must have been 
successful at elevating the border price.  However, these figures provide little evidence that large 
expansions in expenditure on interdiction have paid large dividends. 
Short-term changes have been more successful, however.  In the short-run a spike in border prices has 
a much larger effect on street prices than is implied by the multiplier M1.  Apparently what happens 
is that dealers continue to honor contracts for delivery to the borders at the agreed price, or with 
modest markups, in the face of cocaine shortages. As  those shortages cascade through the system, 
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shortages have not been sustainable, but there have been short-term success stories. 
The bottom line is that the supply of cocaine increased from the early 1980s into the late 1980s. 
Although direct evidence is lacking, circumstantial evidence is strong, because cocaine prices fell as 
demand grew.  Only an increased supply of cocaine would seem to explain that pattern.  Starting in 
the early 199Os, we have both direct and indirect evidence of a relatively constant supply of cocaine 
as measured in pure units.  The direct evidence is that the production of coca changed very little over 
time, so that after discounting for crop eradication and seizures, the supply to the United States has 
been fairly constant. The indirect evidence -  based on a slight fall in both the price of cocaine and the 
number of users -  has been discussed already. 
I 
I 
Heroin 
As was true of  cocaine, heroin is a basically agricultural product who conversion from poppy to gum 
to base requires simple and inexpensive chemical processing. Much of the price at the border must 
reflect the success of interdiction. Much of the markup from border prices to street prices must result 
from successful law enforcement. 
There are some similarities between trends in heroin prices and trends in cocaine prices.  The highest 
price seemed to predate the drug war’s inauguration, and the explanations would seem to be the same 
for cocaine as for heroin.  Thereafter the pattern for heroin differs from the pattern for cocaine, 
because heroin prices continued to fall through the 1990~.’~  Changes in supply-side forces may 
explain these differences.  Before 1995, most heroin came from Southwest and Southeast Asia; 
thereafter, South America became the dominant supplier. Currently about 50 percent of the heroin 
used in the United States comes from South America (essentially Colombia) and another 25 percent 
comes from Mexico.  It seems reasonable that Colombian dealers had to cut prices in order to 
supplant Southeast and Southwest Asian sources as the principal American suppliers. 
.. 
Another difference between cocaine and heroin is that the latter seems to have developed a bifurcated 
market. Some heroin users continue to purchase low purity heroin, suitable only for injection, at 
prices represented by the highest curve in Figure 3.  Other heroin users purchase high purity heroin, 
suitable either for injection or snorting (or repackaging and resale), at prices represented by the 
second highest curve in Figure 3.  Over time, more and more purchases may have been made at this 
higher purity level,” so the actual price paid at retail declined more than is shown by either line alone. 
Another difference between heroin and cocaine is that the occasional peaks, which seem to be 
characteristic of the trends in cocaine prices, do not appear in the heroin price series. That is, 
estimated heroin prices show considerable variation from period to period, but there are no patterns of 
price spikes, observed first at the importation level, that cascade through to the retail level.  This 
Io  South American heroin may have made earlier inroads on Asian suppliers. It is difficult to tell, because 
knowledge about the source of heroin comes from the Drug Enforcement Administration’s Heroin 
Signature Program and Domestic Monitor Program. Before about 1995, DEA lacked a “signature” for 
South American heroin, so  it could not tell how much of seizures and purchases actually came from South 
America instead of  Asia.  See Rhodes, Truit, Kling and Nelson, 1998. 
Information is mostly anecdotal. However, over time, a higher proportion of DEA purchases came from 
the higher purity level. We cannot be  sure whether this results from  a change in the availability of heroin 
on American streets or from a change in DEA enforcement practices. 
I’ 
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associated with specific cocaine price spikes (Layne, Bmen, Johnston and Rhodes, 2000), the same is 
apparently not true for heroin.  m 
The price markup for heroin could be estimated from the curve: 
However, this seems like a much less interesting problem for heroin.  First, the border prices for 
heroin are more difficult to determine, because heroin is imported in a variety of  small amounts, 
presumably by personal couriers who often swallow the drug.  Consequently we lack a good 
benchmark for border prices.  Second, the border price appears to be a small fraction of the street 
price. Very roughly, the border price is probably around $150 per pure gram.  Injectors might pay 
close to $2000 per pure gram when they buy drugs of low purity, and  this suggests that the border 
price is a small component of the street price.  Some users, those who purchase higher quality heroin, 
pay much less per pure gram, perhaps closer to $200 per pure gram.  In this case, street prices appear 
to be a significant multiple of border prices.  Nevertheless, public authorities have not had a great deal 
of success increasing the border price, so the size of the markup would seem to be a moot point. 
Figure 3 
Estimated Price  per  Pure Gram of  Heroin at  Fie Levels  of  Distribution 
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Marijuana 
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Trends in marijuana prices follow an entirely different pattern from trends in cocaine and heroin 
prices.  In the early 1980s. marijuana prices were relatively low, and foreign supplies seemed readily 
available.  But interdiction programs have been more successful with marijuana, for reasons that are 
readily understood. Marijuana is bulky.  While 12 metric tons of heroin satisfies the U.S.  market, it 
takes about 100 to 130 metric tons of marijuana to meet consumer demands.  Heroin has no odor, but 
marijuana smells and is easily detected. Thus, interdiction was successful at intercepting marijuana, 
with the consequence that marijuana prices increased. 
Higher marijuana prices seemed to have attracted increased domestic production, including indoor 
and hydroponic production, which would have been cost-prohibitive  without price increases and relief 
from foreign competition. Marijuana prices peaked at all distribution levels sometime around 1992. 
Since then, as domestic production has grown, prices have fallen. 
The trends are deceptive, because the quality of marijuana has not remained constant.  The level of 
marijuana's active ingredient, THC, seems to have increased from the 1980s into the 1990s. 
Apparently the THC  content has not changed as much during the 1990s although it is possible to find 
reports of  marijuana purchases with exceptionally high THC  content. 
The size of the markup would seem to be less meaningful than its counterpart for heroin and cocaine. 
The latter two necessarily have foreign sources, so  we can meaningfully ask how border prices affect 
street prices.  In contrast, much if not most marijuana comes from many domestic sources. The 
principal impact of foreign interdiction may be to encourage development of a domestic industry, so 
the regression does not represent what we purport it to represent. 
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I 
Estimated Marijuana Prices at Four Levels of Distribution 
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Methamphetamine 
A similar explanation may apply to the methamphetamine market.  Mexico has been a principal 
foreign source of  methamphetamine shipped into the Unites States, mostly to the West Coast.  A 
nascent domestic industry has begun to develop, based mostly on many small-time operations that 
probably supply a small number of users, but also including a few large-scale operations. Figure 5 
seems to show that street prices have declined much more rapidly than importation prices.  This 
seems sensible if small-scale domestic industry has increasingly provided methamphetamine to 
American users. 
Abt Associates Inc.  Drug Demand and Supply  25 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not Figure 5 
Estimated Price per  Pure  Gram  of  Methamphetamine at  Three  Levels  of  Distribution 
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Chapter 4  The Demand for Illicit Drugs 
Overview 
According to the National Strategy, prevention programs can reduce the initiation and continuation of 
drug use by youths and young adults. Law enforcement and treatment can reduce the prevalence of 
drug use by those who are habituated. Supply-based programs reinforce these effects by reducing the 
availability and increasing the price of  illicit drugs. But by how much do prices affect drug use 
decisions? That is the question addressed in this chapter. 
This chapter first turns  to the initiation of drug use, reporting trends in initiation rates, and  providing 
estimates of  how increases and decreases in drug prices have affected those trends.  It then takes the 
next step to study the prevalence of continued drug use by those who had tried drugs in the past. 
Finally, it reports findings about trends in drug use by those whose hardcore use (and other factm) 
result in legal entanglements with the criminal justice system.  a 
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There must be a “first time” for anyone who uses an illicit substance, so we can meaningfully identify 
a time when a survey respondent first tried marijuana, cocaine and other drugs. The National 
Household Survey on Drug Abuse poses this question to members of households, so data are readily 
available for 1982 through 1996. This study uses responses to that question to study trends in the 
initiation of drug use and whether or not changes in drug prices have any effect on those trends. 
A problem seems apparent. Trying a drug for the first time is probably not the same thing as 
initiating drug use, at least as social scientists and policy makers think of those terms.  Initiation 
would seem to require some unspecified degree of repeated behavior.  Unfortunately, with one 
exception, the NHSDA provides no additional indication about repeated behavior, and we have to use 
the “first time” response to study initiation of drug use. The exception is that respondents who said 
they tried a drug for the first time during the same year as they were interviewed also answered a 
question about how frequently they used the drug during that year.  For them, we can determine how 
frequently “first-time” use implies repeated behavior.  Table 3 provides estimates taken from the 
NHSDA. 
For this study, we assigned every survey respondent to an age cohort based on the respondent’s age at 
the time of  the 1996 survey.  For example, if a respondent was 16 at the time of  the 1996 survey, he 
or she was identified as a member of the sixteen-year-old age cohort. Note that a respondent who was 
I5 at the time of the 1995 survey was also a member of the sixteen-year-old cohort, as was a 
respondent who was 14 at the time of the 1994 survey. 
Cohort identity is an important variable in most of  the following analysis because patterns of  drug use 
vary markedly with cohort identity. It is extremely important to remember that cohort identity is a 
marker for time periods, and therefore, is a basic control variable for factors that we cannot otherwise 
observe, yet that have a strong influence on drug use. Even a casual inspection of time-series from 
the Monitoring the Future Survey shows that the risk of trying drugs is cyclical, so that some cohorts 
are at higher risk of trying illicit drugs than are other cohorts.  We cannot observe that risk directly; 
we use cohort identity as a proxy variable. 
This study used a two-population survival model to study the time until initiation of drug use.  Recall 
from earlier that the two-population model divides the population into two parts: those who will try 
the drug at some time and those who will never try the drug.  The statistical analysis estimates the 
probability of ever trying the drug. It also estimates the timing of  first use conditional on being a 
member of  the first group-those  who will try the drug at some time.  For a technical exposition of 
the two-population survival model, see. .... The probability of ever trying a drug was first modeled as 
a function of age-cohort (AGE) and place (PLACE). That is: 
AGE 
AGE2 
AGE3 
PLACE 
The respondent’s age at the time of the 1996 survey divided by  100.  The division plays 
no substantive role in the analysis but it facilitates the computing algorithm. 
The square of the respondent’s age at the time of  the 1996 survey. 
The cube of the respondent’s age at the time of the 1996 survey. 
Place dummy variables represent the place where the interview took place. There were 
26 places which we do not identify by request of the Office of Applied Studies. 
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@ 
MEN 
BLACK 
A dummy variable denoting men 
A dummy variable denoting African-American 
Likewise, patterns of initiation were similar for Hispanic and other men and women, but very 
different from the patterns for Whites and Blacks. We combined Hispanic and other men and women 
and introduced two additional variables into the analysis: 
MEN  same as above 
HISPANIC  A dummy variable denoting that the respondent was Hispanic. 
The split-population model has three basic ingredients. First, there is a probability that a respondent 
will ever try a drug, modeled here as a logistic distribution. This is modeled as a function of cohort 
membership (AGE, AGE2 and AGE’),  place (PLACE), gender and race/ethnicity.  Second, there is 
failure rate for those who ever fail, assumed to be distributed as log-normal. The mean for the log- 
normal distribution is modeled as a function of cohort membership (AGE and AGE2),  gender and 
race/ethnicity, but not place.  Third, the standard deviation in the log-normal distribution is modeled 
as a function of cohort membership (AGE and AGE2),  gender and race.  It was impractical to include 
AGE3 and PLACE as variables that affect the log-normal distribution because the estimation was too 
slow to converge. The specification was linear-additive in these arguments. 
Once we settled on a model that represented trends in initiation rates, we introduced a drug price 
variable into the analysis. The price variable might have been included as a time-varying covariate, 
but this was very complicated and beyond the scope of  this study. Instead, we determined the average 
drug price for the period between the respondent’s 14” and 18” birthday, reasoning that prices during 
this period would have the strongest effect on the respondent’s decision to initiate drug use. 
The AGE’ and AGE3 variables were dropped from the analysis once drug prices were introduced into 
the models. This raises a difficult problem.  The introduction of cohorts into the analysis is 
necessitated by ignorance of time-varying factors that actually affect peoples’ decisions to initiate 
drug use. The age cohort variables represents factors that are specific to cohorts, and if that 
representation is thorough, then the age cohort variable already represents the influence of temporal 
price variation.  Because of a technical problem know as collinearity, however, the inclusion of both 
drug prices and age cohort can mask the effect of the factor of greatest interest in this study -  changes 
in drug prices.  By dropping the AGE2  and AGE’ cohort variables (but retaining the AGE cohort 
variable), we hope to be able to identify the effect that prices have on initiation decisions. 
Dropping AGE’  and AGE’  is problematic, however. To the extent that the age cohort represents 
factors other than drug prices, the statistical model is misspecified.  The consequence is that the drug 
price variable might be accounting for other factors (attitudes about the social acceptability of drug 
use, for example) that both vary coincidentally with drug prices and that affect decisions about 
initiating drug use.  We cannot be sure of whether or not excluding the age cohort variables provides 
a better or vmse picture of the relationship between drug use initiation and drug prices.  a 
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selection probabilities based on place, race and age. We did not weight the data in the analysis. 
Because these variables entered the model as covariates, parameter estimates are consistent without 
weighting.  Whatever advantages accrue from weighting the data, estimates of the covariance 
matrices would have been extremely complicated if weighting had been employed. (See Deaton, 
1997, for a discussion.) We chose to avoid this complication and to focus on the questions of  greatest 
interest. 
@ 
Continuation of Drug Use 
It is tautological that only those who had initiated drug use at some time could continue drug use at a 
later date, so this part of the analysis was limited to data about reported drug use by those who said 
they had tried the drug. The dependent variable in this part of the analysis was the frequency of drug 
use during the last year, defined as none, less than weekly, and weekly.I2 The analysis used an 
ordered-probit model that adjusted for the first-stage selection bias.  (The requirement for an 
adjustment stemmed from the decision to limit the analysis file to those who had initiated drug use. 
In fact, the adjustment seemed to have very little effect on the analysis and could have been ignored.) 
Details are provided in Appendix B.  The model was linear-additive in its arguments. 
Many additional variables enter into the analysis of the continuation of drug use: 
DRUGAGE 
EDUC 
EDUC2 
MARRIED 
EMPSTAT2 
FAM-INC 
MALE 
AGE 
AGE2 
WHITE 
BLACK 
HISPAN 
PLACE 
MJ PRICE 
ALCPRICE 
COCPRICE 
This is the respondent’s age at the time he or she first used the drug. For marijuana, 
this variable is WAGE and for cocaine it is COCAGE. 
Education level, coded as years of school completed 
The square of education level 
A dummy variable denoting that the respondent was married 
A dummy variable denoting that the respondent was employed. 
Family income 
A dummy variable denoting men 
Age at the time of the interview (not cohort age) 
The square of age at the time of the interview 
A dummy variable denoting White 
A dummy variable denoting African-American 
A dummy variable denoting Hispanic 
A dummy variable denoting where the interview took place 
Marijuana prices 
Alcohol prices 
Cocaine prices 
We used reported consumption during the last year because the professional literature (and our own 
experience) with self-report data shows that people are more willing to report more distant drug use 
The NHSDA imputes responses for individuals who say they did not use in the last year yet gave 
contradictory information elsewhere during the interview.  We discarded those imputations, thereby 
accepting the individual’s original response.  Between 1994 and 1996, imputations were only 3 to 4 percent 
for marijuana, so this decision probably was irrelevant. But imputations were close to 7 percent for cocaine 
and between 8 and 12 percent for heroin.  How to treat impctations is more troubling for cocaine and 
heroin. 
12 
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dependent variable. That is, prices are the average price for a specified drug during the year before 
the respondent was intervie~ed.’~  For example, if the respondent was interviewed during the first 
quarter of 1998, then the price was the average price for the last three quarters of  1997 and the first 
quarter of 1998. All three prices -  marijuana, alcohol and cocaine -  entered into the analysis to test 
for cross-price effects. The Substance Abuse Manual Health Service Administration imputes positive 
responses for some respondents. We chose to assume that those respondents had not, in fact, used the 
drug.  This  affected about five percent of the reported drug users. 
a 
Hardcore Drug Use 
The analysis of hardcore drug use used an ordered-logistic model.  The differences between an 
ordered-probit model (used above) and an ordered-logistic model (used here) are negligible. The 
probit model assumes a normal distribution, a convenient assumption because of our desire to develop 
a two-step estimator, as explained in the technical appendix. We could not readily accomplish this 
without being able to assume a bivariate normal distribution for error terms. See the appendix. On 
the other hand, the logistic distribution allows us to deal with overdispersion.  This  is not readily 
accomplished with the probit model. 
We completed separate analyses for each of four drugs: cocaine, heroin, marijuana and 
methamphetamine. In each case, the dependent variable was the number of days that the respondent 
used the drug during the month before the survey, coded as “none,” “1-10 days,” and “more than 10 
days.”  The first category was labeled as “no use,” the second as “occasional use,” and the third as 
“heavy use.”  The analysis might have used different categories, but these corresponded to 
categorizations used in other reports, so they were convenient. 
Excluding drug price variables, the independent variables were: 
ILLEGCAT 
INCOME 
AGE 
AGE2 
HIGRADE 
HIGRADE2 
TIME 
TIME-6 
TIME-24 
BLACK 
WHm 
HISP 
SEX 
Income from illegal sourced 
Income from legitimate sources 
Age in years 
Age squared 
Highest grade achieved 
The square of highest grade achieved. 
Time, coded zero at the beginning of the period and increasing by 1 per  quarter. 
Time, coded 0 before the 6*  quarter, coded 1 at the beginning of the 6*  quarter, and 
increasing by 1 per quarter thereafter. 
Time, coded 0 before the 24* quarter, coded 1 at the beginning of the 24* quarter, 
and increasing by 1  per quarter thereafter. 
Coded 1 for African-American and coded 0 otherwise. 
Coded 1 for White and coded 0 otherwise. 
Coded 1 for Hispanic and coded 0 otherwise. 
Coded 1 for Male and coded 0 otherwise. 
l3  We did not have a price estimate for every city that entered the analysis. When the price was unknown, v;z 
substituted the national average price. This would seem to be innocuous because, in a fixed-effects model, 
the level of prices does not matter -just  the  trends. 
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beginning of the 6*  quarter of data and another new slope at the beginning of the 24* quarter. Coding 
the time trend as a quadratic gives results that are substantively the same as those reported based on 
this linear spline, but the spline gives more reasonable projections. Hence we report results based on 
the spline. 
Place Identifiers for the NHSDA 
The Office of Applied Studies of the Substance Abuse Mental Health Service Administration 
provided Abt Associates with the means to match price data with the place where the NHSDA 
respondent was interviewed. OAS was particularly concerned that NHSDA interviews remained 
confidential, and OAS felt the best way to protect confidentiality was to mask the place identifiers 
used in this study.  We had no objections to this reasonable restriction because reporting statistics 
specific to place identifiers was peripheral to the principal finding reported here.  However, the reader 
should be aware that the place identifier (in the form of a dummy variable) always entered the 
statistical analyses. We never report the parameter estimated associated with the dummy variables. 
Demand for Marijuana 
We analyzed the demand for marijuana in three stages. The first stage was the initiation of marijuana 
use.  For this purpose, we used data from the NHSDA. The second stage was the continuation of 
marijuana use.  For this purpose, we also used the NHSDA.  The final stage was hardcore drug use 
among arrestees. For this final purpose, we used the DUF data. 
Initiation of Marijuana Use 
The NHSDA asks respondents when they first tried marijuana. The answer to that question was the 
dependent variable in this analysis. 
Using marijuana for the first time is not the same thing as becoming a marijuana user.  Table 3 
tabulates the frequency of marijuana use during the year when a respondent said that he or she had 
tried marijuana for the first time.  The table shows the survey years down its rows and it shows the 
number reporting use in each user category across the columns. Just over 40 percent of the 
respondents said they used marijuana once or twice during the year that they tried marijuana for the 
first time, and just over 70 percent said they used it less frequently than once per month.  About 11 
percent had become weekly users. 
Table 3 
First Tlme Use MJ Was During Survey Year 
(Weighted) 
mmt  mQnrslrsy USED YARIJUABIA  PAST  12 "TU 
lrrqurncyI daily  13-6 dayall-2 dayaI25-51  dall2-24 &IS-11  dayI3-5  dayall-2 daymi 
I  l/wk  I/wk  Iya/y.u  IY~WU  Ia/yoar  //War  I/Par  I 
Total 
.................................................................................. 
1990  I  29267 I  18777 I  85593  I  56057 I 120258 I 153919  I  261269  I  527439 11252579 
1991  I  56139 I  18163 I  62466 I 106525  I  146473 I 148591 I  174790 I 778104 11491251 
1992  I  32966 I 9513.9  I  73381 I  37404 I  181058 1  94314 I 186889 I 565874 lll81400 
1993  I  51808 I  51618 I  86859 I 198409 I  195512 I 211740 I 375385  I  672767 11855097 
.................................................................................. 
.................................................................................. 
.................................................................................. 
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latter part of  the last year would have been unable to say that he or she had been a regular user.  That 
is, there is a bias toward reporting infrequent use.  Nevertheless, these findings show that many if not 
most of those youths who try marijuana do not progress to using it at an appreciably rate during the 
year that they tried it. We would like a better indicator of  when a person first started using marijuana, 
but regrettably, a better indicator is unavailable.  We begin with an analysis of trends in initiation 
rates. 
Using the split-population survival model described earlier, we estimated separate regressions for four 
raciaethnic groups and two genders. Those regressions included AGE and AGE’,  but not AGE3. 
Because of the exclusions of AGE3, the regressions failed to show the recent increase in initiation 
rates for teenagers, but the regressions were nevertheless useful.  They demonstrated that White and 
African-American men and women have similar initiation rates.  Apparently, White and Black men 
and women could be combined into a single analysis provided that dummy shift variables were 
included for each race and gender.  Likewise, the initial analysis showed that Hispanic and other men 
and women had similar initiation rates.  Apparently Hispanic and others could be combined into a 
single analysis provided dummy variables were included as controls for race and gender. 
We do not show the results from the initial analysis here.  Instead, we focus on the results for 
initiation of drug use for White and Black men and women combined and on the results for Hispanic 
and Other men and women combined. The variable AGE3  does enter this analysis, which allows the 
estimated trends to follow an S-shaped curve. That is, the model might show that lifetime initiation 
rates are especially high for the youngest cohorts, lower for cohorts who are somewhat older, higher 
for cohorts who are much older, and lowest for the oldest cohorts. Exclusion of the AGE3  variables 
affords a model of  trends that increase and then decrease with AGE, or a model of trends that 
decrease and then increase with AGE, but inclusion of the AGE3 variable affords a more complicated 
model of trends. 
Table 4 shows the means and standard deviations for variables that entered the analysis. One place 
was excluded from the place variables as the residual category to prevent multicollinearity. 
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parameters (QCONST to BLACK) is associated with the probability of ever trying marijuana. A 
positive parameter means that the probability of  ever using marijuana increases. The second series 
("CONST  to BLACK) is associated with the median time until trying marijuana for those who elect 
to try the drug. A positive parameters means that the median age for first use increases. And the 
third series (SCONST to BLACK) is associated with the standard deviation of  the time until trying 
the drug. Table 6 shows results for a companion regression for Hispanic and other men and women. 
------- 
QCONST 
AGE 
AGE-2 
AGE-3 
MALE 
BLACK 
TCONST 
AGE 
AGE-2 
MALE 
BLACK 
SCONST 
AGE 
AGE-2 
MALE 
BLACK 
............................... 
5.8328  0.7004 
-50.1281  6.1933 
151.2611  17.9281 
-149.9006  16.9131 
0.2856  0.0170 
-0.4330  0.0185 
3.7543  0.0356 
-6.1129  0.2041 
9.7740  0.2889 
-0.0304  0.0032 
0.0348  0.0035 
-0.3055  0.0808 
-7.6715  0.4909 
10.1890  0.7378 
0.0456  0.0116 
0.0107  0.0124 
----------_-_____ 
8.328  0.0000 
-8.094  0.0000 
8.437  0.0000 
-8.863  0.0000 
16.810  0.0000 
-23.356  0.0000 
105.466  0.0000 
-29.949  0.0000 
33.833  0.0000 
-9.580  0.0000 
10.064  0.0000 
-3.781  0.0001 
-15.628  0.0000 
13.809  0.0000 
3.930  0.0000 
0.858  0.1954 
This is a large sample, so it probably is not surprising that parameters are statistically significant. The 
parameters associated with places are relatively easy to interpret.I4  Other variables are more difficult 
to interpret, because the same variables affects the probability of every trying marijuana, the average 
time until trying marijuana for those who do try it, and the standard deviation for time until trying 
marijuana. These three effects have to be combined to make sense of them, and that combination is 
nontrivial. 
A figure is more helpful for interpreting the statistics. Figure 6 shows the estimated probability of 
trying marijuana by the age of 20 as a function of age cohort membership. To derive these estimates, 
we set all variables except AGE equal to their mean values. We did not weight the data to reflect the 
NHSDA's higher selection probability for African-Americans, so the actual relationship may be 
somewhat higher or lower than depicted here.  Nevertheless, we are interested in the trend, which is 
reflected in the unweighted curve. 
The place identification was determined at the time of the interview, not at the time that the person tried the 
14 
drug.  Thus, we should assume that the place variable is measured with considerable imprecision. 
~~~~ 
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much lower for older cohorts, and it is somewhat lower for younger cohorts. It appears to be 
relatively low for the youngest cohorts, but we must remember that the estimates for the youngest 
cohorts are almost pure projections.  For example, we cannot see any drug use beyond age twelve for 
members of the age twelve cohort because they were twelve at the time of the last (1966) interview. 
Figure 6 
Probability of  Trying  Marijuana  by  Age  20 
Estimates and  Projections for White  and  Black  Males  and  Females 
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Another problem with this figure is that it understates drug use by the older cohorts.  Others have 
shown that as people age they become increasingly likely to deny that they had tried a drug in the 
past.  The size of the resulting bias is not so large that it would offset the trends observed here, but it 
would reduce the differences between the initiation rates for younger and older cohorts. 
Figure 7 provides a different view of the same phenomena.  This figure shows the estimated timing of 
first marijuana use for members of four different cohorts. The youngest was age 15 in 1996; the 
oldest was age 45 in the same year.  (Note that a vertical line drawn at 20 years will intersect each of 
these lines at the estimates reported in the previous figure.) The youngest cohort seem  to experiment 
with marijuana at an older age than the 25 and 35-year-old cohort members, but the youngest cohort 
also seems to have the highest projected lifetime probability of ever using marijuana. The estimated 
lifetime probability of trying marijuana should be heavily discounted, because we cannot accurately 
predict that lifetime probability from just three years of data for that youngest, age 15 cohort. 
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Proportion Trying  Marijuana as of  a  Specified Age 
Estimates and Projections for White  and  Black  Males and Females 
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Indeed, we are skeptical about the accuracy of the predictions for the youngest cohorts.  They seem to 
come from a period of elevated drug use (The University of Michigan, December 1999), but the 1996 
survey is too soon to learn much of the increase that had become more apparent by the time of the 
1997 and 1998 surveys. 
The pattern of initiation of drug use is different for Hispanic and other men and women.  Table 6 
reports parameter estimates and standard errors. 
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AGE 
AGE-2 
MALE 
HISPANIC 
SCONST 
AGE 
AGE-2 
MALE 
HISPANIC 
-3.2090 
5.7965 
0.0014 
-0.0617 
-1.2701 
-2.0905 
3.5491 
0.1035 
-0.0840 
0  -2814 
0.4290 
0.0053 
0.0120 
0.1183 
0.7438 
1.1680 
0.0184 
0.0378 
-11.402  0.0000 
13.512  0.0000 
0.267  0.3949 
-5.159  0.0000 
-10.738  0.0000 
-2.811  0.0025 
3  :039  0.0012 
5.624  0.0000 
-2.221  0.0132 
As before, some of the parameters have a straightforward interpretation, but others do not. .Figures 
are more useful when interpreting results.  Figure 8 shows the estimated probability of trying 
marijuana by the age of 20 for Hispanic and other males and females. The cohort effect is very 
different from that observed for White and African-American males and females. Initiation rates 
decrease monotonically as cohorts get older.  That is, members of the youngest cohorts seem to be at 
the highest lifetime risk of experimenting with marijuana. 
Figure 8 
Probability of  Trying  Marijuana  by  Age  20 
Estimates and Projections for Hispanic  and Other  Males  and Females 
10  15  20  25  30  35  40  45  50  55 
Age  in  1996 
Figure 9 shows the estimated age at initiation of marijuana use for Hispanic and other males and 
females.  (Slicing this figure at the age of 20 gives the same estimates as the previous figure for the 
probability of trying marijuana by age 20.)  The figure implies that young Hispanic (and other) men 
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and African-Americans, we are skeptical about the estimates for the youngest cohorts, because they 
are based on few years of  data. Still, the trend toward greater risks among the youngest cohorts 
seem  apparent from these findings. 
Figures 7  and 9 show differences across cohorts in the initiation of marijuana use, but they do not tell 
us anything about how marijuana prices have affected those initiation rates.  For this purpose, we 
drop AGE'  and AGE3 from the model and substitute a new variable:  MJPRICE,  the average price for 
marijuana when members of a cohort were between the ages of  12 and 18 as well as for White and 
African-American males and females. Table 7  reports descriptive statistics. Table 8 reports 
regression results for white and African-American males and females. Table 8 reports the same for 
Hispanic and other males and females. The analysis was restricted to age-30 cohorts and younger 
because we did not have adequate price data for older cohorts. 
Figure 9 
Proportion Trying  Marijuana as of  a  Specified Age 
Estimates and Projections  for Hispanic and Other Males  and Females 
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We also simplified the estimator for the standard error by assuming that the standard error was 
constant across cohorts, races and genders.  Consequently, the price of marijuana enters the statistical 
model at two places. The first time, it affects the probability of ever using marijuana. If the 
probability of ever using marijuana falls as the price of marijuana increases, then the parameter 
estimate associated with marijuana prices should be negative. The second time that marijuana price 
enters the model, it affects the median time until first use. If marijuana prices cause people to begin 
use at a later age, then this parameter associated with marijuana prices should be positive. 
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proportion of respondents who had not tried marijuana at the time of the survey. MJPRICE  is the 
marijuana price divided by  10. This division facilitated the computing algorithm but otherwise has no 
effect on the analysis. 
Table 7 
For White and African-American men and women, the price of marijuana has a negative (parameter 
estimate equal to -0.6180  ) and statistically significant  (t-score equals -3.387)  effect on the 
probability of ever using marijuana. The price of marijuana has an unexpected negative (parameter 
equals -0.0308)  effect on the median age of first marijuana use, but that effect is not statistically 
significant (t-score equals -1.360).  See Table 8.  t 
QCONST  1.9305  0.5090  3.793  0.0001 
MJPRICE  -0.6180  0.1824  -3.387  0.0004 
MALE  0.2555  0.0310  8.230  0.0000 
BLACK  -0.4637  0.0336  -13.821  0.0000 
COHORT  -2.4137  1.1416  -2.114  0.0172 
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Parameters  Est  hates  Std. err.  Est./s.e.  Prob. 
TCONST  3.1165  0.0476  65.457  0.0000 
MJPRICE  -0.0308  0.0227  -1.360  0.0869 
MALE  -0.0232  0.0059  -3.947  0.0000 
BLACK  0.0352  0.0064  5.500  0.0000 
COHORT  -0.9651  0.1080  -8.940  0.0000 
SCONST  -1.5159  0.0127  -119.416  0.0000 
........................................................ 
Looking at the results for Hispanic and other males and females, marijuana prices have a negative 
(parameter estimate equals -0.4973) and statistically significant (t-score equals -3.174)  effect on the 
probability of ever using marijuana. These results show a perverse effect of marijuana prices on the 
timing of initiation. The parameter is negative (-0.0521)  and statistically significant (t-score equals 
1.957).  Taken literally, these findings imply that when marijuana prices are high, fewer people try 
marijuana, but those who do try it at any earlier age. A literal interpretation is probably inappropriate, 
however, for reasons discussed elsewhere (Rhodes, 1989).  We should just take these findings to 
mean that high prices have a salubrious effect on reducing experimentation with marijuana because 
the effect associated with the probability of ever using marijuana sets a ceiling on eventual use. 
The substantive effect that higher marijuana prices have on initiation rates is difficult to infer from :he 
tables, but graphs are helpful.  Figure 10 plots the relationship between marijuana prices and the 
probability of trying marijuana by age 20 for White and African-American males and females. Figure 
11 is the counterpart for Hispanic and other males and females. All variables except mariju:A-  L  , 
were held constant at the average values observed in these data. The marijuana prices depicted tiere 
represent the range of marijuana prices observed between 1981 and 1998. but this range is wiJ6  P ahan 
that observed for the price variable used here, that is, the average price that prevailed when cohort 
members were between the ages of  12 and 18 ($9.15  per gram to $13.89).  Consequently, we should 
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of use falls as marijuana prices increased from $9.15 to $13.89. 
Figure 10 
Proportion Trying Marijuana by Age  20 as a  Function of  Price 
White  and Black Men  and Women 
I  I  I 
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Marijuana Price in  1998 Dollars 
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Proportion Trying  Marijuana  by  Age  20 as a  Function of  Price 
Hispanic and Other Men  and Women 
6 
Marijuana  Price in  1998  Dollars 
These findings imply that the likelihood of trying marijuana decreases as marijuana prices increase. 
Perhaps children and young adults are truly sensitive to marijuana prices, but these findings might 
imply that prices were high during periods when marijuana was relatively scarce. The scarcity rather 
than the price per se could produce the results reported here. 
Is there external verification for these findings? We know of no other researchers who have studied 
the relationship between prices and the decision to try marijuana, but a simple reanalysis of more 
expansive NHSDA  data provides independent evidence that initiation rates are lower when prices are 
high.  See Figure 12. 
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Smoothed Price of Marijuana and First Time Use  of  Marijuana 
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In Figure 12, the first-time use of marijuana estimates are taken from the 1998 National Household 
Survey on Drug Abuse, Table 41.  “The numerator of each rate is the number of persons in the age 
group [  12 to 173 who first used the drug in the year (times 1,O00), while the denominator is the 
number of person who were exposed to the risk of first use during the year, adjusted for their 
estimated exposure time (exposure time was expressed in years).” (NHSDA, p. 24).  The price of 
marijuana was derived from estimates in the price series report.  We took the price per gram 
estimates for the retail sample (e  10 grams), and to smooth the curve, calculated a three-year moving 
average. 
Marijuana prices increased from 1981 through 1990; initiation rates decreased over that same span of 
time.  Prices seemed to have reached a plateau in the early 1990s. although it is difficult 
to tell, because estimates from the early 1990s have high sampling variation.  Initiation rates were 
stable during most of this period, although they increased in 1992.  Marijuana prices decrease from 
1993 through 1997; with the exception of the last year of data, marijuana initiation rates increased 
during that same period. These findings are consistent with the statistical analysis -  higher marijuana 
prices imply lower initiation rates. 
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Does the price of marijuana affect current marijuana use for those who have tried marijuana at some 
time in the past?  To answer this question, we selected from the NHSDA  all respondents who were 
between 12 and 50 at the time of the survey. We categorized responses about use during the last year 
as “did not use in the last year,” “used but less than weekly,” and “  used at least weekly.” 
We analyzed these data separately for respondents who were older than 18 and for respondents who 
were younger than 19. This was a pragmatic decision, because we had more measured covariates for 
adults than we had for youths, and those variables had different meanings when applied to youths and 
adults. 
A total of 18,760 adults said they had tried marijuana.  About 70 percent of them had not used in the 
year before the survey, about 19 percent had used at less than a weekly rate, and 10 percent had used 
at a weekly rate.  A total of 2,630  youths said they had tried marijuana.  Of those who had tried, 25 
percent had not used in the last year, about 50 percent used less than weekly, and about 24 percent 
said they used weekly.  Table 10 reports other descriptive statistics for adults (19 and over) and 
youths (under 19). 
Table 10 
Past Year Use of Marijuana as a Function of  Marijuana Prices 
Descriptive Statistics 
----  -  --e-- 
Over 18  18 and under 
Var  i  ab1  e  Mean  Std Dev  Mean  Std Dev 
NTL-MARF  14.3963  2.7618  14.1760  2.7969 
ALC-PRCF  1.3885  0.2781  1.3749  0.3105 
COCPRCFl  2.0082  0.4736  2.0174  0.5014 
WAGE  0.1756  0.0403 
MJAGE2  0.0325  0.0175 
EDUC  0.7700  0.1446 
EDUC2  0.6139  0.2149 
MARRIED  0.3824  0.4839 
EMPSTAT2  0.7595  0.4274 
FAk-INC  8.7945  3.1138  8.3520  3.1341 
MALE  0.5060  0.5000  0.5372  0.4987 
AGE  0.3022  0.0742  0.1624  0.0149 
AGE2  0.0968  0.0496 
WHITE  0.4936  0.500Q  0.3542  0.4784 
BLACK  0.2218  0.4155  0.1982  0.3988 
HISPAN  0.2630  0.4402  0.4251  0.4945 
CASES  18760  2623 
--------------------____________L_______--------- 
Table 11 reports parameter estimates, standard errors, and t-scores for two models: a model that 
adjusts for selection of those who had used marijuana in the past and a model that does not adjust for 
that selection. In fact both models lead to the same conclusions, but before comparing them, note that 
the models have different parameterizations.  In the model that adjusts for selection, a positive 
parameter means that marijuana use falls as the variable associated with that parameter increases. In  0 
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increases. 
Recognizing that the signs are different in these two models, the fwst inference is that marijuana use 
falls as marijuana prices increase. Elasticity” estimates can be based on the average price and usage 
level that prevailed between 1988 and 1996. About 10 percent of all adults who had tried marijuana 
used it on a weekly basis.  A 10 percent increase in marijuana prices would reduce weekly use to 9 y2 
percent.  This is an elasticity of -0.50.  About 20 percent said they had used less frequently than 
weekly.  A 10 percent price increase would reduce occasional use to 19 % percent, which is an 
elasticity of -0.25.  Overall, then, a 10 percent price increase would reduce use from 30  percent to 
about 29 percent, with the elasticity being -0.33. 
It may be reasonable to expect a larger elasticity for heavy users than for occasional users.  Marijuana 
is a larger part of the market basket of the former, and that may be why they are more responsive to a 
price change.  Also, some of  the heavy users become occasional users, and this partly offsets the 
number of occasional users who quit, so  elasticity would be less for occasional users. 
These elasticity estimates are smaller than estimates reported by others (see the earlier literature 
review), but that would be expected because these estimates use a different base.  The numerator in an 
elasticity calculation is the change in the use group (a number like -0.005  here) divided by the 
percentage of people in that use group (a number like 0.10 here).  The base is relatively large in our 
estimates, because it is limited to people who have tried marijuana.  Others have included everybody 
in the base, which will inflate the elasticity estimate, causing it to be larger than our estimate.  Of 
course, this does not mean that our estimate is correct and the estimates of  others are wrong, because 
the base chosen for calculation depends on what the researcher seeks to measure, and for that there is 
no universal standard. 
(I) 
Is  The estimates are based on a nonlinear model, so elasticity varies with price.  Evaluating elasticity at the 
mean is convenient, but evaluation at other values would produce somewhat different results. 
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CONST 
MJ PRICE 
ALCPRICE 
COCPRICE 
MJAGE 
WAGE2 
EDUC 
EDUC2 
MARRIED 
EMPSTAT2 
FAM-INC 
MALE 
AGE 
AGE2 
WHITE 
BLACK 
HISPAN 
CORR 
Alpha 
Alpha-1 
Alpha-2 
-1.2003  0.3637  -3.300 
0.0200  0.0036  5.498  -0.0198 
0.0773  0.1376  0.561  -0.0993 
0.1324  0.0653  2.027  -0.1286 
7.7853  1.5710  4.956  -13.7411 
-16.6100  3.0376  -5.468  24.8671 
-1.0411  0.4333  -2.403  1.0976 
1.0753  0.2937  3.662  -1.1194 
0.3700  0.0228  16.249  -0.3718 
0.1257  0.0246  5.107  -0.1262 
0.0271  0.0036  7.537  -0.0271 
-0.3783  0.0199  -19.033  0.3744 
5.2976  1.0341  5.123  -6.8879 
-3.0269  1.6553  -1.829  6.1346 
-0  -2223  0.0694  -3.203  0.1731 
-0.2842  0.0712  -3.989  0.2527 
-0.0384  0.0708  -0.543  0.0006 
0.0482  0.0093  5.186 
-0.2091  0.0151  -13.882 
-2.9881 
-2.1774 
0.0036 
0.1375 
0.0663 
1.0751 
2.6329 
0.4409 
0.2982 
0.0223 
0.0249 
0.0036 
0.0200 
0.9975 
1.5454 
0.0695 
0.0711 
0.0706 
-5.46 
-0.72 
-1.94 
-12.78 
9.44 
2.49 
-3.75 
-16.65 
-5.08 
-7.43 
18.68 
-6.91 
3.97 
2.49 
3.56 
0.01 
0.3104  -9.63 
0.3100  -7.02 
We have less interest in other variables entering this statistical model, but some comment may be 
useful.  There is some variation in the prevalence of marijuana use by place.  One place has a 
parameter of -0.3439 and another place has a parameter of 0.0587. But variation by place does not 
seem especially large as  judged by the size of the t-scores, which generally do not approach 
significance. 
The earlier that a respondent tried marijuana (MJAGE), the higher the probability that he will have 
used it during the current year.  This inference is based on the observation that the parameter 
associated with MJAGE is positive, implying that current marijuana use is lower when age first tried 
marijuana is higher. The negative size associated with the square of MJAGE is noteworthy because it 
implies that, at some age, the relationship between current use and WAGE reverses itself.  However, 
WAGE  equals actual age at first use divided by 100, so the relationship is monotonic over the range 
of interest to us here. 
Education is years of education completed.  Practically, then, the negative sign associated with 
education (EDUC)  and the positive sign associated with its square (EDUC2) implies that marijuana 
use falls as education increases. Males are more likely to use marijuana than are females. Marijuana 
use is lower if a person is married; it is lower if he is employed; use falls as income increases.  0 
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CONST 
MJ-PRICE 
ALPRICE 
COCPRICE 
FAF-INC 
MALE  . 
AGE 
WHITE 
BLACK 
HISPAN 
CORR 
Alpha 
Alpha-1 
Alpha-2 
-0.3196 
0.0062 
-0.2043 
0.3331 
0.0196 
-0.0877 
1.6815 
-0.1787 
-0.1295 
-0.1254 
0.0239 
0.3293 
0.5040 
0.0082 
0.2758 
0.1421 
0.0073 
0.0472 
1.6552 
0.1520 
0.1580 
0.1552 
0.0185 
0.0227 
-0.634 
0.746  -0.00597 
-0.740  0.19853 
2.344  -0.33754 
2.672  -0.02000 
-1.858  0.10866 
1.016  -2.58929 
-1.176  0.16992 
-0.820  0.11971 
-0.808  0.08344 
1.290- 
14.518 
-1.93362 
-0.54404 
0.0082 
0.2751 
0.1403 
0.0073 
0.0449 
1.5529 
0.1509 
0.1562 
0.1503 
0.4724 
0.4713 
-0.72 
0.72 
-2.41 
-2.73 
2.42 
-1.67 
1.13 
0.77 
0.56 
-4.09 
-1.15 
Looking at the analysis of drug use by people under 18, there is no evidence that children and young 
adults (under 18) are sensitive to the price of marijuana, at least when they decide how frequently to 
use the drug. In fact, with some exceptions, few  variables in this model seem to be strong predictors 
of current marijuana use.  Males are more likely than female to be current users.  Marijuana use 
decreases as family income increases. Some places may have lower use rates than the excluded 
place, but these effects are not large. Curiously, the use of marijuana has a negative association with 
the price of cocaine. 
Overall, then, it appears that adults who have tried marijuana some time in the past reduce current 
level consumption when marijuana prices are high and increase current level consumption when 
marijuana prices are low.  Children and young adults do not seem to be sensitive to marijuana prices, 
nor is there a cross-price elasticity with respect to alcohol prices. Note that the sample size was much 
smaller (2,623) for children than it was for adults (18,760).  Perhaps a larger sample for children 
would yield different results. 
Hardcore Marijuana Use 
Across the DUF  sites, 64  percent of arrestees said they had not used marijuana in the month before 
the interview. Another 24 percent said they had used it on 10 of fewer days during that month, and 
12 percent said they had used it on more than 10 days. 
I 
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INTERCPl 1  -0.8506  0.2663 
INTERCP2 1  0.6572  0.2663 
MARPRCFl 1  -0.2763  0.0363 
COCPRCFl 1  -0.3165  0.0622 
HERPRCFl 1  -0.1570  0.0338 
ALCPRCF  1  0.2246  0.1290 
ILLEGCAT 1  0.8522  0.0135 
INCOME  1  0.00167  0.00222 
AGE  1  -0.0514  0.00364 
AGE2  1  0.000039 0.000055 
HIGRADE  1  0.2088  0.0118 
HIGRADE2 1  -0.0113 0.000558 
TIME  1  -0.0300  0.00913 
TIME-6  1  0.0426  0.0106 
TIME-24  1  -0.0130  0.00286 
BLACK  1  0.7377  0.0567 
WHITE  1  0.7539  0.0569 
HISP  1  0.2554  0.0574 
MALE  1  0.4996  0.0124 
ATLANTA  1  -0.5052  0.0839 
CHICAGO  1  -0.5525  0.0993 
CLEVE  1  0.0651  0.1271 
DALLAS  1  -0.6601  0.1093 
DC  1  -1.4594  0.1097 
DETROIT  1  -0.3935  0.0823 
HOUSTON  1  -0.2974  0.0354 
LA  1  -0.9259  0.1299 
MIAMI  1  -0.8894  0.1246 
10.2013 
6.0896 
57.8506 
25.9284 
21.5192 
3.0305 
3971.6628 
0.5695 
199.3055 
0.5002 
311.6243 
412.4360 
10.7951 
16.2118 
20.7299 
169.1814 
175.5832 
19.7728 
1614.9548 
36.2433 
30.9402 
0.2627 
36.4770 
177.0568 
22.8556 
70.4602 
50.7734 
50.9492 
0.0014 
0.0136 
0.0001 
0.0001 
0.0001 
0.0817 
0.0001 
0.4504 
0.0001 
0.4794 
0.0001 
0.0001 
0.0010 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.6083 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
-0.046854 
-0.128563 
-0.098957 
0.019225 
0.179804 
0.002132 
-0.255684 
0.013613 
0.263964 
-0.300882 
-0.170165 
0.231340 
-0.028486 
0  -200265 
0.170046 
0.055181 
0.123084 
-0.061624 
-0.061936 
0.008244 
-0.093472 
-0.200800 
-0.045688 
-0.041030 
-0.146149 
-0.092066 
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Variable DF  Estimate  Error  Chi-square Chi-square  Estimate 
~  ~~~ 
NEWORL  1  -0.2232  0.1106  4.0766  0.0435  -0.030781 
NEWYORK  1  -0.8595  0.1245  47.6927  0.0001  -0.119383 
PHIL  1  -0.7415  0.1260  34.6353  0.0001  -0.105442 
PHOENIX  1  -0.3418  0.0863  15.6753  0.0001  -0.050488 
SANANTON 1  -0.4983  0.0468  113.5157  0.0001  -0.066181 
SANDIEGO 1  -0.5664  0.1164  23.6967  0.0001  -0.077357 
mar. Reference site is STLOUIS  . kl=6, k2=24 
There was a very strong negative relationship between the price of  marijuana and its level of use.  On 
the logit scale, and with prices in $10 units, the parameter estimate was 4.2763 (p <O.OOOl).  The 
implied elasticity (evaluated at the 1998 price of $10.2) for hardcore users and moderate users was - 
2.79 and -2.65  respectively.  Thus a one percent increase in the price of marijuana reduces the 
proportion of hardcore marijuana users by 2.79%. 
Arrestees appear to be sensitive to marijuana prices.  This makes sense, because marijuana is 
potentially a large part of their market basket, so price increases are a potentially large part of their 
income.  In addition, they have access to other intoxicants, including alcohol.  Note that as the price 
of alcohol goes up, the consumption of  marijuana goes up, apparently because marijuana users are 
willing to switch between marijuana and alcohol depending on relative prices. 
The results imply additional cross-price elasticity effects. Marijuana use falls when cocaine or heroin 
prices increase. Several different interpretations are possible.  Marijuana use may be a complement to 
cocaine and heroin use so that cocaine users use less marijuana when they restrict their cocaine use, 
and the same for heroin users.  Another possibility is that an increase in cocaheheroin prices has a 
strong income effect, and habitual users reduce all consumption (including marijuana) to compensate 
for having to spend more on cocaheheroin. Still another explanation is that higher cocaheheroin 
prices are the result of  a tightening drug market, and this tightening might restrict access to marijuana. 
e 
We have less interest in the effect of  other variables on the level of marijuana use.  However, 
marijuana use falls with age, and increases and then decreases with education (maximum at grade 9). 
Males are heavier users than females, and use is higher for those with illegal income, although there is 
no relationship between use and amount of (legal or illegal) income.  Whites, African-Americans and 
Hispanics all have higher use rates than “other” races.  Use is higher in some places than others:  for 
example, use is relatively high in St. Louis  and low in Washington, D.C 
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initiation of Cocaine Use 
The analysis of the demand for marijuana provides a template for the study of cocaine use (including 
crack). Nevertheless, studying the demand for cocaine poses special problems, many of which stem 
from the low reported prevalence of cocaine use among members of households. The analysis begins 
with an estimate of how cocaine prices affect initiation rates.  As before, the analysis used responses 
to the question: At what age did you first try cocaine?  Table 14 shows that this is a very different 
question than asking when cocaine use was initiated. 
The table shows the weighted number of respondents who said they used cocaine for the first time 
during the year of  the interview. Note that almost 60  percent of those who tried cocaine for the first 
time during the year of the interview also said that they had used cocaine  just 1 to 2 times during that 
year. Possibly, then, many if not most of those respondents did not use cocaine again during the year. 
Almost 80 percent of them said they had used less frequently than once per month, and fewer than 10 
percent said they used weekly.  The question about age at first use does not seem to indicate initiation 
of  cocaine use, but nevertheless, it is the only measure at our disposal. 
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Parameters  Estimates  Std. err.  Est./s.e.  Prob. 
-------------------c----------------------------------- 
QCONST  -1.7815  0.7334  -2.429  0.0076 
AGE  -1.2669  6.5419  -0.194  0.4232 
AGE-2  37  -7734  19.1343  1.974  0.0242 
AGE-3  -65.8194  18.2720  -3.602  0.0002 
MALE  0.2836  0.0183  15.484  0.0000 
BLACK  -0.4117  0.0216  -19.058  0.0000 
TCONST  3  -2059  0.0753  42.576  0.0000 
AGE  -2.6856  0.4432  -6.060  0.0000 
AGE-2  6.0632  0.6474  9.365  0.0000 
MALE  -0.0058  0.0047  -1.250  0.1056 
BLACK  0.0368  0.0067  5.525  0.0000 
SCONST  -0  -7332  0.2065  -3.551  0.0002 
AGE  -8.4972  1.2274  -6.923  0.0000 
AGE-2  15.2317  1.8256  8.343  0.0000 
MALE  0.0048  0.0205  0.236  0.4065 
BLACK  0.2135  0.0251  8.507  0.0000 
The place where a person lives has a large effect on his or her decision to try cocaine. The risk of 
trying cocaine is relatively high in some places (0.361 1;  0.2830) and comparatively low in others 
(-0.3134;  -0.3516).  As was true when examining the initiation of marijuana use, cohort effects are 
statistically significant, but they are difficult to interpret, so we use graphics for understanding. 
Figure 13 reports the predicted probability of trying cocaine by the age of twenty for White and 
African-American males and females. 
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Probability of  Trying  Cocaine by Age  20 
Estimates and Projections for White  and Black  Males  and  Females 
* 
0 
r4 
0 
0 
0 
9 
9 
9 
Age  in  1996 
According to Figure 13,  members of the age 30 cohort were at greatest risk of trying cocaine by age 
20. This finding seems reasonable given what is known  about the cocaine epidemic. People who 
were 30-years-old in 1996 were in their late teens and early twenties at the peak of the cocaine 
epidemic in  the middle and later 1980s. Members of the youngest cohort appear to be at relatively 
low risk of trying cocaine, but caveats are necessary. We  cannot see much of the drug use career for 
the youngest cohorts, but data that are more recent than were available for this study imply increased 
recent use among youths. Specifically, results from MTF  (The University of  Michigan, 1999)  show 
that the lifetime prevalence of cocaine use has increased fairly steadily from 1991 to 1999  for 8*,  10* 
and 12" graders. 
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Estimates  and Projections for White  and  Black Males and Females 
00  5  10  15  20  25  30  35  40  45  50 
Age  in Years 
Figure 14 projects the age as first-time use for four age cohorts. If we were to draw a vertical line at 
age 20, it would intersect these four curves at the same estimates reported in the previous figure. The 
figure implies that the age 35  cohort is at the highest risk of trying cocaine. The age 25 cohort is 
somewhat lower.  Older and younger cohorts are at lower risks, at least over the range of data for 
which we have much confidence -  less than age 30. 
Table 17 reports parameter estimates for the initiation of cocaine use by Hispanic and other men and 
women. 
Parameters  Estimates  Std. err.  Est./s.e.  Prob.  Gradient 
.................................................................. 
QCONST  0.2755  0.9338  0.295  0.3840  -0.0000 
AGE  -13.2997  8.4412  -1.576  0.0576  0.0000 
AGE-2  41.9158  24.9465  1.680  0.0465  0.0000 
AGE-3  -47.5359  24.0753  -1.974  0.0242  0.0000 
MALE  0.4932  0.0274  18.028  0.0000  0.0000 
Parameters  Estimates  Std. err.  Est./s.e.  Prob.  Gradient 
_____________-_---------------------------------------------------  a 
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BLACK 
SCONST 
AGE 
AGE-2 
MALE 
BLACK 
-0.1725 
2.9483 
-1.1611 
4.1577 
0.0443 
0.1671 
-1.8650 
-1.2664 
6.0422 
0.4961 
-0.0094 
0,1097 
0.1011 
0.6430 
1.0221 
0.0095 
0.0651 
0.2715 
1.7419 
2.7755 
0.0363 
0.1148 
-1.572 
29.172 
4.068 
4.685 
2.566 
-1.806 
-6.869 
-0.727 
2.177 
4.320 
-0.260 
0.0580 
0.0000 
0.0355 
0.0000 
0.0000 
0.0051 
0.0000 
0.2336 
0.0147 
0.3975 
0.0000 
-0.0000 
0.0002 
0.0000 
0.0000 
-0.0000 
0.0002 
-0.0004 
-0.0001 
-0.0000 
0.0000 
-0.0004 
Again, there are important differences across places. The risk of trying cocaine is relatively high in 
one place (0.7450) and comparatively low in another (-0.751 1).  Figure 15 shows estimates of the 
probability of trying cocaine by age 20  as a function of cohort identity. 
Figure 15 
Probability of  Trying  Cocaine  by Age  20 
Estimates and Projections for Hispanic  and Other  Males  and Females 
Age  in  1996 
The estimated risk of trying cocaine is highest for the youngest cohorts and lowest for the oldest 
cohorts. Again we should be skeptical of the estimates for the youngest cohorts, because we see only 
a limited amount of data about them.  Focusing on the risk for the age twenty cohort, the inference is  a 
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Apparently, Hispanic and other men and women who are  just entering adulthood are at about the 
same risk of trying cocaine as are their White and African-American counterparts. 
Figure 16 provides a different view of the risk of trying cocaine as a function of age cohort. 
,  Figure 16 
Proportion Trying  Cocaine  as of  a  Specified  Age 
Estimates and Projections for Hispanic  and Other  Males  and Females 
c‘! 
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The pattern is clear.  Among Hispanic and other men and women, the oldest cohorts have the lowest 
risk of trying cocaine. The youngest cohorts seem to have the highest risk. 
Given these findings about Hispanic and other men and women, we should revisit the MTF  findings 
reported earlier.  According to the MTF finding, lifetime use of marijuana was 8 percent for 12* 
graders in 1991 but close to 6 percent between 1992 and 1995.  This “6%  group pertains to our age 
19-22 age cohorts. Then in 1997-1999, about 10 percent of all seniors had tried cocaine. This “10%” 
group corresponds to our age 15-17.  The MTF shows a clear upward trend in experimenting with 
cocaine. Perhaps Hispanic and other men and women account for this increase, so our findings are 
consistent with the MTF.  Alternatively, our data -  which end in 1996 -  are too recent to capture whi;: 
appears to be an increase in cocaine use by American youth. 
Have prices influenced these initiation rates? We drop the AGE2 and AGE3 variables from the 
analysis and add the average price of cocaine experienced by each cohort between the ages of  12 and 
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years old.  The price was divided by 10 because the model converged better when price was scaled. 
Table 18 reports descriptive statistics. 
Table 19 reports regression results for White and African-&rican  men and women; Table 20 
reports results for Hispanic and other men and woman.  The first time that COCPRICE  appears in 
these tables, it is associated with the lifetime probability of  trying cocaine. For both White/African- 
Americans and Hispanidother the parameter has an unexpected positive sign, but it never approaches 
statistical significance (t =  0.08 for White/African-American  Ad  t =  0.89 for Hispanic/other). The 
second time that COCPRICE  appears, it is associated with the median age of initiation for those who 
tried cocaine. The parameter is negative (but not significant) for WhitedAfrican-Americans,  but it 
has the expected positive sign for Hispanicslothers and it is statistically significant (t =  2.50). So 
there is some evidence that cocaine prices have affected cocaine initiation rates, but the evidence is 
not very strong. 
a 
Although there is little evidence that initiation is affected by price, there is no reason to assume the 
null hypothesis -  that cocaine prices have no  effect on initiation rates. In fact, when prices are 
averaged over seven years periods (between the age of 12 and 18 for each cohort), cocaine prices 
have fallen fairly constantly.  As was shown earlier, cocaine prices were high in the early 1980s and 
they fell sharply until about 1988. Thereafter, prices declined gradually, and most of that subsequent 
decline was attributable to the consumer price index. Greater variation in cocaine prices would have 
provided a stronger test of the hypothesis, but given this monotronic decrease in price, a linear trend 
may be indistinguishable from the cohort effect. 
Abt Associates Inc.  Drug Demand and Supply  55 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not . 
i 
f 
1' 
,* 
$7 
a 
k. 
K . 
i- 
4  e. 
f' 
4. 
? 
.. 
QCONST 
COCPRICE 
MALE 
BLACK 
COHORT 
PIMA 
TCONST 
COCPRICE 
MALE 
BLACK 
SCONST 
.  .  COHORT 
-2.7072 
0.0138 
0.2418 
-0.5357 
7.7640 
-0.0332 
2.6688 
-0.0021 
0.0114 
0.0076 
0.9034 
-1.9124 
0.3787 
0.1796 
0.0321 
0.0380 
3.2294 
0.2302 
0.0757 
0.0367 
0.0076 
0.0093 
0.6496 
0.0219 
-7.148 
0.077 
7.523 
-14.098 
2  -404 
-0.144 
35.277 
-0.057 
1.501 
0.813 
1.391 
-87.451 
Table 20 
First Time Cocaine Use as a Function of Cocaine Price 
..................................................  .................................................. 
Hispanic and Other Men and Women  ..................................................  .................................................. 
Mean log-likelihood  -0.392474 
Number of cases  17071 
Parameters  Est  hates  Std. err.  Est./s.e. 
................................................. 
QCONST  -1.1812  0.3879  -3.045 
COCPRICE  0.1716  0.1919  0.894 
MALE  0.4278  0.0409  10.465 
HISPANIC  0.4005  0.0803  4.988 
COHORT  -3.4320  3.3414  -1.027 
TCONST  2.9198  0.0656  44.517 
COCPRICE  0.0881  0.0352  2.499 
MALE  0.0644  0.0105  6.156 
HISPANIC  -0.0181  0.0231  -0.785 
COHORT  -0.9248  0.5430  -1.703 
SCONST  -1.7717  0.0291  -60.954 
Continuation of Cocaine Use 
Having examined initiation rates, we turn to continuation rates.  Given that a person has tried cocahe, 
do current consumption decisions depend on the price of cocaine? To answer this question, we 
created an  analysis  file comprised of people who said they had tried cocaine.  We ran a separate 
analysis for adults (over 18) and children (18 and under).  We consider adults first. 
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50 at the time they were questioned. About 77 percent said they had not used cocaine in the last year, 
another 19 percent said they had used it less frequently than weekly, and 4 percent said weekly. 
Table 2 1 provides descriptive statistics; Table 22 provides regression results. 
Table 21 
Continuation of Cocaine Use:  Descriptive Statistics 
----_-______________------------------------------------------  ----________________--------------------------------_--------- 
----________________------------------------------------------  ----_________________----------------------------------------- 
Var  i  ab1  e  Mean  Std Dev  Variance  Minimum  Maximum 
COCEPS  -0.0960  0.9306  0.8659  -6.0000  3.1406 
0.5315  0.2825  1.0000  3.0000  COCYRFRQ  1.2716 
NTL-MARF  14.4018  2.7350  7.4803  9.9409  21.0294 
ALC-PRCF  1.3861  0.2823  0.0797  0.0000  1.7749 
COCPRCFl  1.9816  0.4379  0.1918  1.3634  4.1740 
COCAGE  0.2081  0.0466  0.0022  0.0315  0.5052 
0.0010  0.2552  COCAGE2  0.0455  0.0228  0.0005 
EDUC  0.7650  0.1447  0.0209  0.0000  1.0000 
0.0462  0.0000  1.0000  EDUC2  0.6061  0.2149 
0.2314  0.0000  1.0000  MARRIED  0.3709  0.4810 
EMPSTAT2  0.7618  0.4260  0.1815  0.0000  1.or)oo 
FAM-INC  8.7777  3.0922  9.5614  1.0000  1,. 0000 
0.0000  1.0000  MALE  0.5489  0.4976  0.2476 
AGE  0.3021  0.0650  0.0042  0.1900  0.5500 
0.0361  0.3025  AGE2  0.0955  0.0425  0.0018 
WHITE  0.5373  0.4986  0.2486  0.0000  1.0000 
0.0000  1.0000  BLACK  0.1758  0.3807  0.1449 
HISPAN  0.2701  0.4440  0.1972  0.0000  1.0000 
---  ----________________-------------------------------------- 
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____________________------------------------------------------------  _________-__________------------------------------------------------ 
Continuation  of Cocaine Use as a Function of Cocaine Price 
________--__________------------------------------------------------  ______-----_________------_----------------------------------------- 
Number of cases  7797 
Parameters  Estimates Std. err.  Est./s.e.Estimate  Error  t-value 
-___-------_________----------------------------------------------- 
CONST  -0.6631  0  -7722  -0.859 
MJ PRICE  0.0134  0.0062  2.161  -0.01462  0.0061  -2.39 
ALC  PRI  CE  0.7504  0.2263  3.316  -0.68156  0.2271  -3.00 
COCPRICE  0.0484  0.1079  0.449  -0.07129  0.1098  -0.65 
COCAGE  7.6762  5.3935  1.423  -1.44232  2.1856  -0.66 
COCAGE2  -13.9317  8.0258  -1.736  5.53749  4.6215  1.20 
EDUC  -0.7902  0.6495  -1.217  0.79083  0.6217  1.27 
EDUC2  1.4397  0.4530  3.178  -1.44518  0.4389  -3.29 
MARRIED  0.3743  0.0375  9.970  -0.37695  0.0373  -10.10 
EMPSTAT2  0.2098  0.0406  5.161  -0.21004  0.0412  -5.10 
FAM-INC  0.0221  0.0059  3.720  -0.02232  0.0059  -3.81 
MALE  -0.2790  0.0331  -8.430  0.27745  0.0335  8.27 
AGE  2.6199  1.9505  1.343  -2.86807  1.9669  -1.46 
AGE2  -0.3962  3.1355  -0.126  -0.38847  3.1132  -0.12 
WHITE  -0.0050  0.1317  -0.038  0.04433  0.1402  0.32 
BLACK  -0.3192  0.1340  -2.382  0.34363  0.1439  2.39 
HISPAN  -0.0785  0.1308  -0.600  0.10133  0.1409  0.72 
TRIGGER 
Alpha  0.0840  0.0256  3.277 
Alpha-2  0.07207  0.5061  0.14 
CORR  -0.1599  0.1292  -1.237 
Alpha-1  -1.02099  0.5064  -2.02 
Table 22 provides no evidence that cocaine consumption is sensitive to the price of cocaine. We tried 
a variety of different model specifications, which included using a past-month indicator of cocaine 
use, and alternative ways of representing prices.  The conclusion was not intrinsically changed. 
Curiously, cocaine use seems to decrease as marijuana prices increase and as the price of alcohol 
increases. We have no ready explanation for those findings. 
Some additional findings deserve comment. COCAGE is the respondent’s age when he or she first 
tried cocaine, and COCAGE2 is the square of that age. The older a person was before he or she tried 
cocaine, the less likely that he or she used cocaine in the last year.  (This is true for values of 
COCAGE up to about 30; thereafter, the effect reverses, but practically nobody tried cocaine for the 
first time after age 30.) Use decreases with age (AGE) although at a decreasing rate (AGE2). 
Men are more likely to use than are females. Cocaine use falls with higher education. It is less likely 
for those who are married, less likely for those who are employed, and cocaine use falls with higher 
income. African-Americans have the highest rates of use. 
We replicated the above analysis (with fewer variables) for people who were 18 and under at the time 
of the survey.  There were only 491 respondents who had tried cocaine by the time of  the interview. 
Of them, 33 said they had not used cocaine in the last year.  About 64  percent used it less frequently 
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Hardcore Cocaine Use 
Across the DUF  sites, 69 percent of arrestees said they had not used cocaine in the month before the 
survey. About 15 percent said they had used it on 10 or fewer days that month, and about 16 percent 
said they had used it more frequently. “Use” is the maximum of days using either powder or crack. 
Table 23 reports the results of  the cumulative logit analysis. 
Table 23 
INTERCPl 1  -8.0597 
INTERCP2 1  -7.0053 
COCPRCFl 1  -0.5485 
HERPRCFl 1  0.0554 
ALCPRCF  1  0.7770 
ILLEGCAT 1  1.7133 
INCOME  1  -0.0157 
MARPRCFl 1  -0.0465 
AGE  0  AGE2 
HIGRADE 
HIGRADE2 
TIME 
TIME-6 
TIME-2 4 
BLACK 
WHITE 
HISP 
MALE 
ATLANTA 
CHICAGO 
CLEVE 
DALLAS 
1  0.3377 
1  0.1452 
1  -0.00953 
1  -0.0434 
1  0.00973 
1  0.0176 
1  1.1251 
1  0.7442 
1  0.7620 
1  -0.00932 
1  -0.2393 
1  -0.1466 
1  -0.4589 
1  -0.2610 
1  -1.1055 
0.2920 
0.2919 
0.0672 
0.0364 
0.0383 
0.1423 
0.0141 
0.00243 
0.00440 
0.000065 
0.0114 
0.000544 
0.00950 
0.0110 
0.00316 
0.0718 
0.0721 
0.0726 
0.0126 
0.0904 
0.1084 
0.1379 
0.1192 
761.7230 
576.1247 
66.5957 
2.3119 
1.4785 
29.8135 
14689.9409 
41.3967 
5894.7708 
4484.9861 
160.8441 
307.2459 
20.8286 
0.7767 
31.1161 
245.1891 
106.3960 
110.0922 
358.5950 
2.6298 
17.9050 
3.5848 
85.9550 
0.0001 
0.0001 
0.0001 
5.1284 
0.2240 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.3782 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.1049 
0.0001 
0.0583 
0.0001 
-0.222852 
0.034850 
-0.007880 
0.066674 
0.360757 
-0.019975 
1.681459 
-1.511839 
0.183639 
-0.253113 
-0.246520 
0.052940 
0.038533 
0.305462 
0.167808 
0.164871 
-0.058927 
-0.017885 
-0.051497 
-0.032938 
-0.156326 
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Variable DF  Estimate  Error  Chi-square Chi-square  Estimate 
_-__--__--__--_-____--------------------------------------------- 
DC  1  -0.9277  0.1192  60.5571  0.0001  -0.127876 
DETROIT  1  -0.8419  0.0899  87.6075  0.0001  -0.097743 
HOUSTON  1  -0.0276  0.0385  0.5150  0  - 4730  -0.003798 
0.0001  -0.127240 
MIAMI  1  -0.7235  0.1354  28.5522  0.0001  -0.074962 
31.2240  0.0001  -0.092497  NEWORL  1  -0.6711  0.1201 
NEWYORK  1  -0.3987  0.1350  8.7211  0.0031  -0.055364 
PHIL  1  -0.6939  0.1369  25.6741  0.0001  -0.098507 
PHOENIX  1  -0.6782  0.0942  51.8481  0.0001  -0.100261 
0.0001  -0.070449  SANANTON 1  -0.5277  0.0535  97.1527 
0.0001  -0.182665  SANDIEGO 1  -1.3384  0.1276  110.0615 
LA  1  -0.8057  0.1413  32.4881 
COC.  Reference site is STLOUIS . kl=6,  k2=24 
There was a reasonably strong negative relationship between the price of cocaine and its level of  use. 
On the logit scale, and with prices in $100 units, the parameter estimate was -0.5485 (p <O.OOol). 
The implied elasticity (evaluated at the 1998 price CF $309) for hardcore users and moderate users 
was -0.70  and -0.26 respectively. Thus a one percent increase in the price of  cocaine reduces the 
proportion of  hardcore cocaine users by  0.70%. 
The cross-price elasticity between heroin or marijuana prices and cocaine use appear to be small, but 
alcohol prices do have a strong effect on cocaine usage.  The higher the price of  alcohol, the higher 
the use of cocaine, reinforcing the inference that drug users search for the lowest priced intoxicant. 
Regarding the effect of other variables, cocaine use increases and then decreases with age (maximum 
at 39) and education (maximum at grade 9).  Females are heavier users than males.  Use is higher for 
those with illegal income, but tends to decrease with amount of  (legal ar illegal) home. African- 
Americans have higher use rates than Whites and Hispanics, who in turn have higher usage rates than 
“other” races. Use is relatively high in St. Louis and low in San Diego. 
Demand for Heroin 
Initiation of Heroin Use 
Following the same estimation procedures applied to marijuana and cocaine, we estimated the time 
until first use of heroin, separately for White/African Americans and for Hispanidother.  Table 24 
provides descriptive statistics. Tables 25 and 26 provide results for WhitelAfrican-Americans and 
Hispanidother respectively. 
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--___------_________-------------------------------------  ......................................................... 
Age at First Use of  Heroin:  White and Black Males and Females 
------------______---------------------------------------  ......................................................... 
Number of cases  36680 
Parameters  Est  hates  Std. err.  Est./s.e. 
QCONST  17.9247  4.2815  4.187 
AGE-2  468.5139  88.4853  5.295 
MALE  0.3003  0.0392  7.652 
TCONST  5.3858  0.6608  8.151 
AGE-2  14.6597  4.1173  3.561 
BLACK  0.0181  0.0253  0.717 
SCONST  0.1383  0.4589  0.301 
AGE-2  9.0122  3.3401  2.698 
0.0475  0.631  MALE  0.0300 
___------_______---_----------------------------- 
AGE  -169.9971  33.7889  -5.031 
AGE-3  -421.1580  76.6851  -5.492 
BLACK  -0.0127  0.0444  -0.285 
AGE  -11.8134  3  -2978  -3.582 
MALE  -0.0138  0.0248  -0.556 
AGE  -7.5464  2.3940  -3.152 
BLACK  -0.0251  0.0524  -0.479 
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QCONST 
AGE 
AGE-2 
AGE-3 
MALE 
HIS  PANIC 
TCONST 
AGE 
AGE-2 
MALE 
HISPANIC 
SCONST 
AGE 
AGE-2 
MALE 
HISPANIC 
--___---_________--------------------- 
1.9999  3.5118  0.569 
-41.8954  28.5481  -1.468 
121.2022  77.1892  1.570 
-113.6855  69.1448  -1.644 
0.3891  0.0603  6.450 
0.1615  0.1198  1.348 
3.1386  0.8122  3.864 
-0.3868  3.9813  -0.097 
0.3666  5.1551  0.071 
0.518  0.0294  0.0568 
-0.0423  0.1023  -0.413 
-1.5219  1.0639  -1.930 
1.0094  5.4081  0.187 
-0.1411  7.4656  -0.019 
-0.1510  0.1318  -1  -146 
-0.0827  0.2346  -0.353 
These regressions are difficult to interpret.  For Whites and African-Americans, the risk of trying 
heroin varies from place to place. The risk is especially high in one place (0.5887),  and it is relatively 
high in others (0.3983;  0.3 166).  It seems comparatively low in another (-0.7582).  Men have a higher 
initiation rate than females. The cohort effects are difficult to interpret, because they appear at 
different places in this regression.  Furthermore, the parameters associated with the cohort effects 
have extremely high parameter values, and we suspect they are not reliable.  Figure 17 graphs these 
results. 
Figure 17 suggests that projected lifetime heroin use was especially high for cohort members who 
were between 40 and 45 in 1996. They would have been in their late teens and early twenties at the 
beginning of the 1970s. a time associated with elevated heroin use.  The  more interesting finding is 
the apparent elevated risk for more recent cohorts. The apparent reduction in risk for the very 
youngest cohorts should probably be ignored, because it is based on scant data. Figure 18 
summarizes results for Hispanic and other Americans. As before, the youngest members of the 
Hispanic and other cohorts were at especially high risk of trying heroin. These findings are consistent 
with results from MTF (The University of Michigan, 1999),  which show increased experimentation 
between 1991 and 1999 among 8*,  IO'  and 12* graders. 
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whether or not price had an  effect on experimentation. Table 27 reports results. 
Table 27  ...............................................  ............................................... 
First Time Heroin Use as a Function of Heroin Price  ............................................. 
-----------------I--------------------- 
Mean log-likelihood  -0.0744739 
Number of cases  50270 
Parameters  Est  imates  Std. err.  Est./s.e. 
QCONST  -2.6054  0.8919  -2.921 
HERPRICE  0.0501  0.0451  1.113 
MALE  0.3170  0.0453 .  6.994 
BLACK  0.0584  0.1166  0.501 
HISPANIC  -0.2073  0.0515  -4.029 
OTHER  -0.3208  0.1782  -1.801 
COHORT  0.67  67-  6.0636  0.112 
COHORT 2  0.7766  10.3058  0.075 
TCONST  2.5786  0.4861  5.304 
HERPRICE  0.0590  0.0215  2.738 
0.0804  0.0297  2.701  MALE 
BLACK  0.1671  0.1078  1.550 
Parameters  Estimates  Std. err.  Est./s.e. 
HIS  PAN1  C 
OTHER 
COHORT 
COHORT 2 
SCONST 
HERPRICE 
MALE 
BLACK 
HISPANIC 
OTHER 
COHORT 
COHORT 2 
-0.0462 
0.0787 
0.8068 
-  -0.1305 
-2.2761 
0.2265 
0.1779 
0.4405 
-0.0420 
0.3453 
-0.1973 
0.1551 
0.0279 
0.1664 
3.3328 
5.7830 
1.2018 
0.0968 
0.0991 
0.1780 
0.0963 
0.3369 
8.5271 
15.1680 
-1.655 
0.473 
0.242 
-0.023 
-1.894 
2.341 
1.796 
2.475 
-0.436 
1.025 
-0.023 
0,010 
As  before, price enters this regression in three places.  The first time it enters the regression, it affects 
the probability of  ever trying heroin.  We expect the parameter estimate to be negative.  In fact, it is 
positive, but not statistically significant. The second time that heroin price enters this regression, it 
affects the median time until trying heroin.  We expect a positive sign, and the result is both 
consistent (parameter =  0.059) and statistically significant (t =  2.74).  The  third time that price enters 
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the regression, it affects the variance, increasing it apparently (parameter = 0.44 and t-score = 2.48). 
This latter effect is difficult to interpret, but overall, these results suggest that experimentation with 
heroin is lower when heroin prices are higher. 
Continuation of Heroin Use 
The NHSDA is not a suitable source for studying current heroin use, because so few people report 
any heroin use.  For example, over 18,000 people answered the NHSDA during 1996. Of those, only 
57 said they used heroin during the last year, and 9 percent of  those responses were imputed. 
Consequently, we did not analyze the price elasticity for heroin. 
Hardcore Heroin Use 
Across 15 DUF sites, 64 percent of arrestees said they had not used heroin during the month before 
the interview. Another 24 percent said they had used heroin on 10 or fewer days during that month, 
and the other 12 percent admitted to using heroin on more than 10 days. Table 28 reports regression 
results. 
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Heroin Use by Arrestees 
-__--__--______--___---------------------------------------------  ................................................................. 
.................................................................  ................................................................. 
Parameter Standard  Wald  Pr >  Standardized 
Variable DF  Estimate  Error  Chi-square Chi-square  Estimate 
INTERCPl 1  -9.9010  0.4927  403.8949  0.0001 
INTERCP2 1  -9.4175  0.4926  365.5633  0.0001 
HERPRCFl 1  -0.1148  0.0674  2.8969  0.0887  -0.072262 
COCPRCFl 1  -0.1695  0.0955  3.1487  0.0760  -0.068879 
MARPRCFl 1  -0.0241  0.0826  0.0848  0.7709  -0.004069 
ALCPRCF  1  0.9432  0.2618  12.9763  0.0003  0.081152 
ILLEGCAT 1  1.6499  0.0203  6577.1004  0.0001  0.347946 
INCOME  1  0.0194  0.00291  44.6107  0.0001  0.024770 
AGE  1  0.2928  0.00669  1916.9503  0.0001  1.455204 
AGE2  1  -0.00325 0.000093  1215.9925  0.0001  -1.134620 
HIGRADE  1  0.2400  0.0189  161.8334  0.0001  0.303138 
HIGRADE2 1  -0.0136 0.000904  225.2500  0.0001  -0.360065 
TIME  1  -0.0587  0.00863  46.2922  0.0001  -0.333941 
TIME-12  1  0.0500  0.0162  9.5528  0.0020  0.231552 
TIME-18  1  -0.0141  0.00971  2.1172  0.1457  -0.048927 
BLACK  1  0.0783  0.1132  0.4'783  0.4892  0.021250 
WHITE  1  0.8296  0.1130  53.9045  0.0001  0.187132 
HISP  1  1.0511  0.1135  85.7387  0.0001  0.226999 
................................................................. 
MALE  1  -0.0477  0.0206  5.3448  0.0208  -0.011748 
ATLANTA  1  -1.6483  0.1502  120.4346  0.0001  -0.202075 
CHICAGO  1  0.7983  0.1465  29.6911  0.0001  0.089380 
CLEVE  1  -0.6951  0.2447  8.0720  0.0045  -0.087566 
DALLAS  1  -1.3007  0.1670  60.6486  0.0001  -0.184367 
DC  1  0.0857  0.1631  0.2761  0.5993  0.011824 
DETROIT  1  -0.2576  0.1338  3  -7079  0.0542  -0.029930 
HOUSTON  1  -1.0531  0.0736  204.8596  0.0001  -0.144906 
LA  1  -0.8826  0.1924  21.0505  0.  OOCl  -0.139069 
MIAMI  1  -2.0885  0.2003  108.7074  0.0001  -0.216259 
NEWORL  1  -0.2271  0.1997  1.2926  0.2556  -0.031369 
NEWYORK  1  0.0161  0.1868  0.0074  0.9314  0.002223 
PHIL  1  -0.6990  0.1926  13.1682  0.0003  -0.099070 
PHOENIX  1  -0.5551  0.1320  17.6927  0.0001  -0.082593 
SANANTON 1  -0.1804  0.0878  4.2267  0.0398  -0.024091 
SANDIEGO 1  -0.7829  0.1727  20.5432  0.0001  -0.106370 
Reference site is STLOUIS . kl=12, k2=18 
Although there was a negative relationship between the price of heroin and its level of use, the 
relationship was relatively weak and not statistically significant.  On the logit scale, and with prices in 
$lo00  units, the parameter estimate was -0.1 148 (p ~0.089).  The implied elasticity (evaluated at the 
1998 price of $1,757) for hardcore users and moderate users was -0.19 and -0.17 respectively. Thus a 
one percent increase in the price of heroin reduces the proportion of hardcore heroin users by 0.19%. 
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9). Males are heavier users than females, Use is higher for those with illegal income, and tends to 
increase with amount of  (legal or illegal) income. Hispanics and Whites have higher use rates than 
African-Americans and “other” races. Use is relatively high in Chicago and relatively low in Miami 
and Atlanta. 
Demand for Methamphetamine 
Hardcore Methamphetamine  Use 
Across the five DUF  sites that entered this analysis, 91 percent of arrestees said they had not used 
methamphetamines during the months before the interview. (They were actually asked about 
amphetamines. Those who tested positive for amphetamines on a urine test had confirmation tests for 
methamphetamines. Most of these were positive for methamphetamines, so treating answers to 
questions about amphetamines as answers to questions about methamphetamines seems justified.) 
About 5 percent said they used methamphetamine 10 or fewer times during the month before the 
interview, and another 4 percent said they used methamphetamines more frequently. Table 29 reports 
regression results. 
Number of Observations: 55261 
Parameter Standard  Wald  Pr >  Standardized  e 
Variable DF  Estimate  Error  Chi-square Chi-square  Estimate 
_-__-_--_--_--_----_------------ 
INTERCPl 1  -5.3349  0.7887 
INTERCP2 1  -4.1405  0.7884 
MTHPRCFI 1  -1.0741  0.1488 
COCPRCFl 1  -0.4311  0.2868 
HERPRCFl 1  0.1316  0.1790 
MARPRCFl 1  0.2069  0.2023 
ALCPRCF  1  1.1484  0.4285 
ILLEGCAT 1  1.1879  0.0388 
INCOME  1  -0.00367  0.00585 
AGE  1  0.1151  0.0139 
AGE2  1  -0.00200 0.000212 
HIGRADE  1  0.3189  0.0384 
._________-__-__-_---------------- 
45.7509  0.0001 
27.5797  0.0001 
52.0747  0.0001  -0.237357 
2.2598  0.1328  -0.155980 
0.5404  0.4623  0.036043 
1.0465  0.3063  0.034366 
7.1830  0.0074  0.099806 
935.9048  0.0001  0.255498 
0.3937  0.5304  -0.004849 
68.6459  0.0001  0.566565 
88.6917  0.0001  -0.693519 
68.9189  0.0001  0.412622 
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Variable DF  Estimate  Error  Chi-square Chi-square  Estimate 
HIGRADE2 1  -0.0159 
TIME  1  -0-  1148 
TIME-12  1  0.2682 
TIME-18  1  -0.1752 
BLACK  1  -1.3199 
WHITE  1  0.8815 
MALE  1  0.2498 
HISP  1  -0.3693 
DALLAS  1  -2.3576 
PHIL  1  -3.8931 
PHOENIX  1  -0.7038 
SANANTON 1  -2.4651 
0.00176 
0.0198 
0.0437 
0.0250 
0.1073 
0.0953 
0.1000 
0.0363 
0.1739 
0.2684 
0.1698 
0.4813 
82.3971 
33.4936 
37.6387 
49.2536 
151.2339 
85.6260 
13.6401 
47.3908 
183.8451 
210.4675 
17.1805 
26.2299 
Reference site is SANDIEGO. kl=12,  k2=18 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
0.0002 
0.0001 
0.0001 
0.0001 
0.0001 
0.0001 
-0.435557 
-0.674829 
1.245017 
-0.604632 
-0.352940 
0.229919 
0.063952 
-0.089901 
-0.524104 
-0.863042 
-0.162108 
-0.523424 
There was a strong negative relationship between the price of methamphetamine and its level of use. 
On the logit scale, and with prices in $100  units, the parameter estimate was -1.0741 
(p <O.OOol).  The implied elasticity (evaluated at the 1998 price of  $140)  for hardcore users and 
moderate users was -1.48  and -1.42  respectively. Thus a one percent increase in the price of 
methamphetamine reduces the proportion of  hardcore methamphetamine users by 1.48%. 
Methamphetamine use increases and then decreases with age (maximum at 29)  and education 
(maximum at grade 10). Males are heavier users than females. Use is higher for those with illegal 
income, but is unrelated to amount of  (legal or illegal) income.  Whites have the highest use rates and 
African-Americans have the lowest rates.  Use is relatively high in San Diego and relatively low in 
Dallas and San Antonio. 
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Marijuana 
The Household Population 
Earlier, this paper discussed targets set by the Office of National Drug Control Policy for reducing 
drug use by the year 2002 and 2007.  One objective of this study is to assess whether or not those 
targets are obtainable, or put more narrowly, whether or not they could be obtained by increasing the 
price of illicit drugs. 
To answer that question, we simulated drug use in the years 2002 and 2007 using two scenarios. In 
the first scenario, drug prices remained at their 1996 levels through 2007.  In the second, drug prices 
doubled linearly through 2007. Presuming people are responsive to increasing drug prices, this 
doubling should result in fewer users and a lower level of use for those who persist. The size of those 
reductions is based on the statistical analysis reported earlier. Specifically, projections of future drug 
use take into account the following: 
current trends based on different initiation rates across cohorts; 
the aging of the drug using populations, notably the fact that people use drugs at a lower 
frequency as they age, and; 
simulated increases in drug prices.  e 
To determine the composition of the population in 2002 and 2007, the analysis started with all 
respondents who answered the 1994, 1995 and 1996 NHSDA. The simulation assigned each 
respondent to a cohort. For example, respondents who were twenty in 1996, nineteen in 1995 and 
eighteen in 1994 were assigned to the twenty-year-old cohort. In general, all respondents who were 
age T in 1996, T-1 in 1995 and T-2 in 1994 were assigned to the age T cohort. Call the data 
combined across these three years the “baseline data.” 
Then, to simulate future cohorts, we “aged” the baseline data. For example, respondents who were 
members of the age T cohort in 1996 were considered to be members of the age T-1 cohort in 1997, 
the age T-2 cohort in 1998, and so on until 2007 when they were considered to be members of the age 
T-1 1 cohort.  In essence, we changed three important variables in the baseline data -  cohort 
membership, the respondent’s age, and drug prices -  to mimic how drug use would change as trends 
(reflected in the cohort effect and aging) and drug prices changed. 
For example, consider the cohort that was age twenty in 1996. We let members of that cohort 
represent people who were twenty in  1997 as well, but in 1997 we treated them as members of the 
nineteen-year-old cohort. (Remember that a cohort was always identified by its members’ age in 
1996.) Then in 1998, we again let them be twenty, but we treated them as members of the eighteen- 
year-old cohort. 
This approach has important limitations. It treats the race/ethnicity and geographic distribution of the 
population as fixed at the distributivn observed in 1996. This seems like a minor limitation, however, 
given the objective of simulating the effect that future prices might have on drug use.  A further 
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Figure 19 reports the actual (until 1996) and projected (after 1996) drug use in three categories: ever 
used marijuana, used marijuana less than weekly during the last year, and used marijuana at least 
weekly during the last year.  These are reported as logarithms so they would fit on the same scale. Up 
to 1996, the curves are based on tabulations of NHSDA  data.  After 1996, each of the three curves 
branches into two parts.  The heavier part is a projection that assumes that drug prices will stay at 
their 1996 levels.  The price-sensitive projections, shown as fine dots, assume that marijuana prices 
will double between 1996 and 2007.  Price change less than a double are proportional and not shown 
here. 
The first thing to note is that the proportion of people who say they have tried marijuana will not 
change much between 1996 and 2007.  This is not surprising, because most people have already 
passed the age at which they are at risk of trying marijuana; new users are just replacing old ones in 
the database. The more interesting finding is that marijuana use will fall over time even if  marijuana 
prices remain constant. This seems reasonable. Cohorts who were around the age of 30 in 1996 have 
the highest lifetime risk of  trying marijuana. But this is an aging group and marijuana use decreases 
with age, so the prevalence of marijuana use is expected to fall. 
The next figure shows projections for weekly users and occasional users.  These projections are the 
same as were shown in Figure 20, but the scale is a natural unit instead of a logarithm. The 
proportion of the population projected to use marijuana falls even when marijuana prices remain 
constant. The principal reason is that the population who were at the highest risk of using marijuana 
at any level -  the age thirty cohort -  have aged.  Many of them will have stopped using drugs and 
others will have restricted their use to levels that are lower than their use levels when they were 
younger. 
0 
Increasing the price of marijuana reduces the use level still further, for two reasons. The frrst is that 
higher prices cause lower initiation rates, and the second is that higher prices result in less use.  Of 
course, the real question is whether or not the Government has the means to double marijuana prices. 
Earlier we speculated that peak marijuana prices were achieved in the early 1990s because the 
Government was successful at restricting foreign marijuana from entering the United States. The 
high prices engendered by that success seems to have promoted a resurgence of domestic production, 
especially hydroponic growing, and other comparatively expensive means of producing marijuana. It 
remains to be seem whether or not the Government can reduce domestic cultivation to a level that 
would once again result in historically high marijuana prices. Almost certainly, if this is to be 
achieved, it will require advances in detection technology, because expansion of  traditional law 
enforcement has yet to show that it can reverse this price decline. 
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Actual  and  Predicted Trends  in  Ever  Use,  Moderate Use  and  Heavy  Use 
Marijuana  with  Future Prices Doubling over Time 
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We also simulated the proportion of  arrestees who would be heavy (more than 10 days per month) 
and occasional (10 or fewer days per month) users of marijuana in the years 2002 and 2007.  Figures 
21,22 and 23 summarize the projections. 
Figure 21 shows the actual, estimated, and projected percentage of arrestees who say they used 
marijuana in the month before the survey. Hardcore users are those arrestees who used marijuana on 
more than ten days during the month before their arrests. The category “moderate or hardcore” 
comprises arrestees who said they used marijuana any time during the month before the month before 
their arrests. The small circles represent the percentage of mestees who said they used marijuana. 
The solid lines represent the estimated percentage who said they used marijuana before 1998 and the 
projected percentage who would say they used marijuana after 1998.  In both cases, the estimates and 
projections set all variables except time, drug prices and age to their mean levels, so the estimates 
were somewhat better than implied by this figure.  Still, the trend shown by these estimates is a good 
reflection of marijuana use among arrestees.  These projections assume that future prices would be 
the same as current prices. 
The second figure shows the same estimates as predictions for hardcore marijuana users along with 
some additional information. Figure 22 has a left-hand axis that reports the percentage of arrestees 
who admitted to heavy marijuana use and a right-hand axis that reports the price of marijuana in 1996 
dollars. The curve toward the top of the figure is the estimated national price of marijuana.  It 
increase slightly, shows a large increase in the early 1990s, and then decreases. The price projection 
is just the estimated 1996 price. 
As before, the circles are the weighted observed percentage of arrestees who said they used marijuana 
on more than 10 days during the month before their interview. The weights are the number of arrests 
in the county. The curve that approximates the circles is the estimated percentage of arrestees who 
said they used on 10 or more days. That prediction comes from setting all variables except prices, 
age, and time to their mean values.  These latter variables were set to the values estimated and 
predicted (price and age) or observed (time) during the quarter.  Of course, the estimates and 
predictions were based on the regression results reported earlier. 
The figure shows that the use of  marijuana generally increases as marijuana prices fall and decreases 
as marijuana prices increase.  The relationship between prices and predicted use is not exact, partly 
because factors other than the price of marijuana are changing (other drug prices and age). 
Nevertheless, the relationship between marijuana prices and use is apparent. 
The three lines that diverge after 1996 are projections.  One projection, based on “modeled price,” 
purports to show what would happen to marijuana use if all price variables follow recent trends. We 
discount this representation heavily, because projecting recent trends for any extended period is 
tenuous. More believable is the second projection, which is based on an assumption that all drug 
prices would stay at their 1998 level.  The third projection results from doubling all illicit drug ~LLS 
-  marijuana, cocaine and heroin prices.  The resulting reduction in marijuana use is dramatic. 
Figure 23 is similar to the previous figure except this new figure does not show prices and the 
projections are based on three scenarios. In the first, all drug prices are fixed at their 1998 levels, and 
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other prices are held constant. Heavy marijuana use falls from near 15 percent to somewhat over 10 
percent of arrestees.  The third scenario doubles all prices, and as a result, marijuana use falls to under 
5 percent of all arrestees. 
These results imply that a successful supply-side program that increases all illicit drug prices could 
have an appreciably effect on reducing marijuana use among arrestees. That is good new and 
reinforces findings about drug use among household members.  The bad news is that prices would 
have to be changed by amounts that go well beyond what supply-size policy has been able to achieve 
recently. 
Figure 21 
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Cocaine 
The Household Population 
Figures 19 and 20 provided projections of  future marijuana use by household members.  Figures 24 
and 25 are counterparts for cocaine.  The curve toward the top of Figure 24 is the projection for 
lifetime use.  As was true of its marijuana counterparts, the trend is projected to stay relatively flat 
through 2007. The reason is that people cannot reverse earlier experimentation with cocaine, so this 
statistic changes very slowly over time, despite any recent increase in hitiation rates. 
Cocaine use is projected to decrease slightly over time, but those trends are easier to see  in Figure 25, 
which reports trends in natural rather than logarithmic units.  The trend toward lower cocaine use is 
modest.  It is accelerated by doubling cocaine prices, but even then, the projected decrease in cocaine 
use does not come close to the National targets.  Furthermore, cocaine prices have fallen, with some 
short-term perturbations, since 1988. It is difficult to find evidence that the Nation could achieve a 
doubling of cocaine prices by the year 2007 absent some favorable technological developments in 
eradication and interdiction. We do not see how supply-based programs alone could help the Nation 
meet its 2002 and 2007  targets. 
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The Arrestee Population 
Results of simulated future cocaine use by arrestees are reported in Figures 26 through 28.  These 
figures have the same structure as their cocaine counterparts, so we will focus on the substance of 
those figures. 
Figure 26 shows trends in the proportion of arrestees who said they used cocaine during the month 
before the survey. The higher curve reports any cocaine use; the lower curve reports hardcore 
cocaine use.  As before, the regressions seem to do a tolerably good job of fitting the observed data. 
These estimates and projections suggest that cocaine use has been falling over time and, if those 
trends persist, will continue to fall into the future. Apparently this will happen because fewer and 
fewer Americans are becoming cocaine users and those who are heavy users are aging out of their 
addictions.  The target for reduced hardcore drug use would be achieved partly without changing 
cocaine prices. 
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Figure 27 projects what would happen if drug prices were increased. The first curve, labeled modeled 
prices, projects what would happen if current trends in drug prices persisted into the future. As 
before, we discount this curve, because drug prices are so difficult to predict.  The second curve - 
already shown in the previous figures -  projects what would happen if prices remained at their 1998 
levels. The final curve projects what would happen if all drug prices were doubled. 
There is good news here.  If drug prices were to be doubled, then hardcore drug use would fall 
considerably. Figure 28 breaks that fall into two parts.  One curve projects what would happen if just 
cocaine prices doubled, and the other curve projects what would happen if all drug prices doubled. 
Apparently, the price of cocaine is the principal factor that drives future drug use.  Given that the 
Nation has exercised so little control over cocaine prices, we are skeptical that trends in hardcore 
cocaine use among arrestees would fall by much more than is projected based on the assumption that 
cocaine prices will remain about the same  as they are now. 
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Heroin 
The Arrestee Population 
Estimated and projected trends in heroin use appear in Figures 29 through 31.  As  before, the sinali 
circles represent observed percentages and the lines represent estimates and projections, The trends 
imply reduced heroin use among arrestees in the future. This may not be an unreasonable inference 
because many  heroin users, who became addicted during epidemics that predate the cocaine 
epidemic, are aging out of addictions. 
Nevertheless, there is reason for caution. For example, the DUF  data may not yet show the effect of 
increased heroin use during the late 1990s that resulted from less expensive, higher purity heroin.  A 
cohort of new users, not represented in these trends, may be among future arrestees. 
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who are hardcore users.  It is difficult to see a strong pattern between heroin prices and heroin usage. 
This may  be because heroin prices did not seem to have even the episodic, transient price spikes that 
are characteristics of cocaine prices.  Whatever price perturbations happened in the heroin prices 
series may have been too brief or too small to have had an appreciable effect on the use of heroin. 
That reasoning is consistent with the findings that the parameter associated with heroin prices was 
only marginally significant (p = .089) in the heroin regressions. 
-  Hardcore  .  Moderate-or-Hardcore 
000  Observed 96  C)Ocl Observed 96 
Figure 3lshows that doubling the price of heroin would reduce heroin use.  Still, the size of the effect 
is considerably smaller than was observed for the demand for cocaine and the demand for marijuana. 
Given that heroin prices have generally decreased throughout the 1990s. it is difficult to see how 
public policy could possibly achieve the projected results that assume a doubling of heroin prices. 
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Methamphetamine 
The Arrestee Population 
Figure 32 shows observed and modeled trends in reported methamphetamine use.  The proportion of 
arrestees saying they used methamphetamine decreased from 1989 to the middle of  1991, increase 
from the middle of  1991 until the beginning of  1995, and thereafter decreased. Deriving trends from 
such cyclical data is precarious and uncertain, so we probably should not put too much weight on 
projections of decreased methamphetamine use based on recent projections. 
Figure 34 shows that changes in the level of  selfTreports  of methamphetamine use have run parallel to 
changes in methamphetamine prices. The relatively low level of self-reports during the early 1990s 
corresponded to a temporal peak in methamphetamine prices.  Then when prices started to fall in 
1992, self-reports of methamphetamine use increased.  That increase abated and reversed as 
methamphetamine prices leveled and increased. Except for the late 199Os, the regressions do a 
tolerable job of fitting these data.  Unfortunately, our inability to fit the last few quarters of data cast 
additional doubt on the projections which, of course, depend heavily on those last few observations. 
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strongly that methamphetamine use is sensitive to prices, so we think it is reasonable to project that 
methamphetamine use would be much lower if prices could be increased than if they remained at 
current levels. This is reflected in Figure 32  and Figure 33.  Note especially that methamphetamine 
use is sensitive to the price of methamphetamine and not to the price of other drugs. 
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Summary and Conclusions 
The 1998 National Drug Control Strategy established an ambitious national agenda for reducing illicit 
drug use by 25  percent as of  2002 and by 50 percent as of 2007.  When it established those targets, 
the Office of National Drug Control Policy recognized that achieving its goals would require a 
multifaceted mixture of supply-based and demand-based programs.  The nature of that mix was 
unknown, however, because there was no solid quantitative evidence of how supply-based and 
demand-based programs would interact to reduce substance abuse. Indeed, there was no compelling 
evidence that available technology targets -  treatment, prevention, or law enforcement - provided the 
means to achieve those. 
Are those targets achievable with the tools at the Nation's disposal? This study did not attempt to 
answer that general question, but it did address a more narrow one: How can supply-based programs, 
which restrict drug availability and consequently increase drug prices, reduce the initiation and 
continuation of drug abuse in the United States? 
This is an  empirical study. Estimates of trends in drug prices come from an  earlier study done by Abt 
Associates Inc. for the Office of National Drug Control Policy.  That earlier study used data from two  0 
Abt Associates Inc.  Drug Demand and Supply  88 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not Drug Enforcement Administration data sources: the System to Retrieve Information from Drug 
Evidence and the Domestic Monitor Program. Data about the initiation and continuation of drug use 
come from multiple administrations  of the National Household Survey on Drug Abuse, mostly from 
the years 1988 through 1996.  Data about drug use by hardcore users come from multiple 
administrations of the Drug Use Forecasting data, mostly from 1989 through 1998. 
We used a survival model, developed especially for this study, to analyze whether or not drug prices 
affect the eventual probability that a youth would experiment with drugs and the age of 
experimentation if he or she did try an illicit substance. We used an ordered probit model, also 
developed especially for this study, to study how drug prices influenced decisions to use illicit 
substances by those who, at some time, had tried drugs at an experimental level.  Finally, we used an 
ordered logistic model to analyze the relationship  between illicit drug prices and the level of 
substance abuse among arrestees. 
Based on  the statistical findings, we projected drug use into the years 2002 and 2007 based on 
different scenarios about how future drug prices will change from their present levels. The purpose of 
this simulation was to estimate how closely a supply-based program that successfully increased drug 
prices could approach the national target of reducing drug use by 50 percent as of 2007. 
Findings 
Drug Prices 
There seems little doubt that the combination of source area programs, interdiction and domestic law 
enforcement have successfully increased the price of illicit drug products to levels that are many 
times higher than would otherwise prevail.  Cocaine, heroin and marijuana are basically agricultural 
products that require minimal inexpensive chemical processing.  If  it were not for law enforcement, 
they might sell for prices that are comparable to aspirin. Instead, users pay many times the price of 
aspirin for typical doses. 
Still, the Nation’s ability to reduce drug availability and to increase drug prices appears to be limited. 
Since about 1988, the prices of cocaine, heroin and methamphetamine  have all fallen or remained 
about the same, despite what was inaugurated in the late 1980s as a war on drugs. The price of 
marijuana increased into the early 1990s, apparently because of  a successful program of interdiction, 
but prices have declined since then as domestic production has supplanted foreign production. Thus, 
while law enforcement efforts have maintained high domestic prices for illicit substances, an 
expansion of law enforcement resources in the 1990s has not had a commensurate effect on drug 
prices. 
Elasticity  of  Demand 
Marijuana 
When marijuana has been relatively unavailable, as reflected in high marijuana prices during the late 
1980s and early 199Os, young Americans have been less likely to experiment with marijuana. Thus, 
Americans who came of age during the early 1980s, when marijuana was relatively inexpensive, were 
more likely to try marijuana than were Americans who came of age in the early 199Os, when 
marijuana cost more.  Marijuana prices have fallen toward the end of the 199Os, while the best 
evidence, available from several sources, indicates that youth have increasingly returned to marijuana  0 
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The evidence is also strong that adults are sensitive to the price of marijuana. The higher the price, the 
smaller the number of  people who use marijuana at both weekly and occasional levels. This is true 
for members of households, who tend to use on an occasional basis, as well as for arrestees, who 
often use at a weekly level or higher. 
Cocaine 
There is some evidence that experimentation with cocaine is less frequent when cocaine prices are 
high, but the evidence is weak.  It would be a mistake to conclude that cocaine prices do not matter, 
however, because these data are not well suited to answering the question. Because cocaine prices 
have decreased fairly steadily since 1981, with just a few short-term perturbations, we could not 
readily distinguish the effect of changes in cocaine prices from other secular trends. 
i 
We did not find household members to be sensitive to cocaine prices. However, arrestees reacted 
strongly to cocaine prices, decreasing their consumption when prices were high and increasing their 
consumption when prices were low. 
Heroin 
Heroin prices seemed to affect experimentation with heroin.  However, the effect was difficult to 
quantify because prices decreased fairly steadily from 1981 through 1998. We may not have been 
able to distinguish price responsiveness from other trends. 
It was not practical to study the demand for heroin using NHSDA data because so few respondents 
admitted heroin use.  Arrestees seemed to be mildly responsive to heroin prices.  When prices were 
high, they reduced their consumption, and they did the opposite when prices were low, but this 
relationship was statistically significant only at the 10 percent level. 
Methamphetamines 
The NHSDA did not ask the requisite questions about methamphetamine use, so the NHSDA data did 
not enter this analysis. Data from five places that had an  appreciable amount of methamphetamine 
use indicated that methamphetamine users were very responsive to prices.  The prevalence of 
methamphetamine use, both by heavy and occasional users, was greatest when prices were low and 
least when prices were high. 
Projections 
Marijuana 
The key question was whether or not the targets set by the National Strategy are obtainable. The 
good news is that the prevalence of marijuana use is likely to fall toward the national goal even if 
marijuana prices remain about the same as they were during the latter 1990s. This  follows because 
cohorts who came of age during the late 1970s and early 1980s were at the highest risk of 
experimenting with marijuana, but continued marijuana use is age sensitive. As those high-risk 
cohorts grow older, fewer of  their members will be active marijuana users.  Because initiation rates 
have been lower in the late 1980s and early 1990s. the disappearance of marijuana use by high-risk 
cohort members will not be offset by an equal increase in new marijuana users. Higher marijuana 
prices would reinforce this change, of course; as of yet there is no evidence of domestic programs that  0 
Abt Associates Inc.  Drug Demand and Supply  90 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not would substantially increase marijuana prices by increasing the production and distribution costs of 
domestic producers.  0 
The uncertainty regarding this otherwise positive conclusion stems from recent increases in marijuana 
use by eighth, tenth and twelfth graders who repoaed substance use to the Monitoring the Future 
Survey. Although the analysis reported here identified the beginning of that upturn in 
experimentation with marijuana use, our data ended in 1996,  so we may have understated this 
resurgence in marijuana use.  The future may not be as  bright as is painted here. 
i 
Cocaine 
Similar patterns apply to cocaine, although for cocaine, the pattern is not so strong. We project a very 
gradual downward trend in cocaine use among household members. Higher cocaine prices would 
reinforce that trend, but the analysis showed little if  any consumer responsiveness by household 
members to increased cocaine prices.  On the other hand, the analysis showed very strong price 
responsiveness by arrestees, whose prevalence of cocaine use was diminishing anyway.  Higher 
cocaine prices would reinforce that trend among heavy users, helping the Nation move toward its 
targets. 
Heroin 
We are less certain about projections for future heroin use.  The NHSDA  is not especially informative 
about heroin use, so we relied exclusively on the DUF  data. Results suggested that the prevalence of 
heroin use would decline even without price increase, apparently because heroin users are an aging 
population whose use would decrease naturally. The problem with this interpretation is that the 
number of heroin users could increase as lower prices and higher punty induce more users into the 
market. 
Methamp  hetumine 
We are also less certain about future levels of methamphetamine use.  Trends imply lower levels of 
future use among arrestees, and those trends would be reinforced by higher prices.  A problem with 
that inference is that it is based on past reports, which are very cyclical and do not point clearly 
toward less use.  Furthermore, methamphetamine use is currently limited to the West and (to a lesser 
extent) the Midwest.  It is difficult to anticipate whether or not methamphetamine use will spread to 
the rest of the country. If  it does, projections are probably in error. 
Conclusions 
Prospective and confirmed drug users are sensitive to the price of drugs, so if the Nation can increase 
the effectiveness of source country programs, interdiction and domestic law enforcement, then drug 
abuse can be reduced appreciably. Given experiences since the beginning of the war on drugs, which 
initiated major expansions in expenditures on supply-based programs, it seems  more reasonable to 
conclude that the Nation will not be able to have any large future influence on decreasing the 
availability and increasing the price of illicit drugs. Of  course, this conclusions rests on observations 
of past trends, and it could be reversed by the introduction of technological advances, such as 
improved ways of detecting cocaine, better informed decisions about the placement of interdicwm 
resources, and improved means of detecting domestic marijuana cultivation. But until those 
improvements happen, it is difficult to be sanguine that supply-based programs can be the major 
means by which the Nation reaches its 2002  and 2007 targets. 
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of alcohol and tobacco by youth, marijuana is by far the most widely abused illicit substance. 
Evidence presented in this report finds that marijuana use wilI decrease in the future even if marijuana 
prices remain the same.  If marijuana prices could be returned to near the levels they attained in the 
early 1990s. then drug use in the household population would decrease even more.  Thus, targets that 
pertain to the drug use by household members are within the Nation’s grasp, although supply-side 
programs alone cannot guarantee they will be reached. 
Trends by hardcore drug users are also encouraging. If  the Nation can hold the line on the initiation 
of illicit drug use, preventing it from returning to the epidemic proportions experienced during earlier 
decades, then as more hardcore drug users age out of their addictions, there will be fewer 
replacements to take their place.  These trends, by themselves, do not appear adequate to reach the 
Nation’s targets for reducing hardcore drug use.  But with the reinforcement of  supply-based and 
expanded demand-based programs (especially treatment), the Nation can be hopeful, if not expectant, 
that drug abuse and its sequela will abate. 
The fly in this prediction ointment is that our data stopped in 1996 and, of course, predictions had to 
be based on data as of that date.  In fact, the Monitoring the Future Survey (University of Michigan, 
1999) shows that ‘lifetime  prevalence of any illicit drug use by seniors reached a peak (since 1975) 
with the class of 1981 and decreased more or less steadily until the class of 1993. Thereafter, 
experimentation has increased more or less steadily through the class of  1999.  Our analysis may not 
fully account for this recent resurgence of use, although nothing in our findings contradict the recent 
trend reported by the MTF. 
The final conclusion, then, is the inevitable call for further research.  If  it is important to monitor and 
explain trends, in order to predict the future, it seems  imperative to do  this with the most recently 
available data. This study provides a template for how data obtained through annual surveys might be 
analyzed, to gain a better understanding of drug abuse. 
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I 
NHSDA DATA ASSEMBLY 
One of the data sets used in the elasticity study consists of alcohol and drug prices 
merged onto data from the National Household Survey on Drug Abuse (NHSDA).  The 
following documents the assembly of this data set.  Tables follow that show the values 
of the variables before and after recoding for both drug related variables and non-drug 
related variables. 
Step 1. Assemble NHSDA Data 
For each year of NHSDA data, only those variables pertinent to the elasticity study were 
extracted from the public use files which were downloaded from the ICPSR (University 
of Michigan’s Inter-University Consortium for Political and Social Research)  website. 
Variables selected covered information such as demographics (race, gender, age), 
financial  status, employment status, education level, marital status, health insurance 
coverage and frequency of drug use (alcohol, cocaine, crack, heroin, marijuana) in the 
past month and past year. 
Since geographic information is encrypted in the NHSDA public use files, the 
downloaded data was merged with a file received from Research Triangle Institute 
which identifies the place for each observation.  The  public use file was merged with its 
respective identifier file for the years 1982, 1988, 1990-1996. [Note: The NHSDA survey 
was changed in the middle of 1994 so there are two  versions for this year.  The 1994-A 
survey is comparable to the surveys from years preceding while the second survey 
1994-B is comparable to surveys from years following.  The observations from the 
beginning of 1994-A were dropped; 4,272 observations were dropped which is about 
20% of the observations from 1994. ] 
a 
The National Household Survey was also conducted in the years 1979,1985, and 1997. 
However, these years of data are not incorporated into the data set.  Since the drug and 
alcohol prices series do not date back to 1979 this year of NHSDA data is not used. 
The 1985 NHSDA public use file is available, however, we do not have the identifier file 
for this year:  Conversely, we have the identifier file for 1997 but this year of NHSDA 
data is not yet publicly available. 
Ultimately, the data set has observations from the 1982, 1988, 1990-1  996 National 
Household Surveys. 
Step 2. Recode NHSDA Data 
Once merged with the geographic information, the separate years of selected NHSDA 
data are set together.  The agency that conducts NHSDA, SAMHSA (Substance Abuse 
and Mental Health Services Administration), has made changes to the survey since the 
96 
 and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 
 been published by the Department. Opinions or points of view expressed are those of the author(s) 
This document is a research report submitted to the U.S. Department of Justice. This report has not first  survey conducted in 1979.  Therefore, variables and their values are not 
necessarily identical year to year.  By researching the variables in the codebooks and 
tracking changes in their names and definitions, it is possible to recode many.  of the 
variables so that they have a uniform value across the years. The recoding process 
included renaming variables, collapsing values of a variable so that they were 
consistent with other years, setting certain responses to missing, and collapsing 
variables with multiple responses into a 0/1 variables (variables with only two 
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0 
/  Step 3.  Select NHSDA Sites for the Elasticitv Study 
Since the elasticity study is longitudinal, places that would be valuable to the elasticity 
study are those that were interviewed with substantial frequency spanning the years 
1979-1  996.  This resulted in 28 places for the analysis. 
Step 4.  Merge Druq Prices onto NHSDA Data 
At this point, the data set for the elasticity study consists only of selected variables from 
the NHSDA surveys for the 28 selected places.  The next step is to merge on the 
quarterly and fiscal prices of cocaine, heroin, marijuana and methamphetamine  for each 
place.  Then the national quarterly and fiscal price of marijuana in each year is merged 
on.  There are two  versions of both the place and national quarterly and fiscal drug 
prices. Version 1 prices correspond to the main effects model and version 2 prices 
correspond to the interactions model. A fiscal price is defined as the average of  the 
current quarter drug price and the past three quarters’ drug price.  (For the very first 
quarter of data, use that quarter’s price as the fiscal price. For the second and third 
quarters, use the average of the current quarter and the previous quarter(s) drug price.) 
The drug prices were prepared using the Drug Enforcement Administration’s STRIDE 
(System To Retrieve Information from Drug Evidence) data. 
There are a few places not matched up to drug price data and proxies were used for 
several places. 
There is no variable for interview month in the 1988 NHSDA data.  As documented in 
the codebook, some of the interviews in the 1988 data set were actually conducted in 
1989 which introduces some error (which cannot be rectified without a month variable). 
Another implication is that the data cannot be broken down into quarters which means 
drug  price data cannot be merged on by quarter.  Instead, the average price in 1988 for 
each drug for each place is taken and is merged onto the NHSDA observations by year 
by place. 
Step 5. Merqe Alcohol Prices onto NHSDA Data 
After merging drug prices onto the NHSDA data set, alcohol prices are merged on.  The 
alcohol prices come from the current Consumer Price Index (CPI) which is the most 
widely used measure of inflation of consumer goods and services including alcohol. 
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appropriate base time period and setting that price index equal to 100, and measuring 
prices changes in relation to that figure.  This allows for comparison between price 
levels at different points in time. ] This bi-annual CPI data for alcohol prices is publicly 
available through the Bureau of Labor Statistics web site. In order for this data to 
coincide with drug price data, linear interpolation was used to produce quarterly alcohol 
prices. The alcohol price data used is collected across 26 metropolitan areas so the 
place data is mapped into areas geographically closest to them without crossing state 
borders (as state alcohol prices are a factor).  Observations from 1981 and 1982 do not 
have alcohol prices since the CPI data is not available before 1984.  There are several 
places that do not have alcohol prices for any year. 
Since there is no variable for quarters in the 1988 data, average prices for each place 
for that year are used.  Also, the Washington DC-Virginia- Maryland- West Virginia CPI 
area alcohol price data does not commence until 1997.  Since there are so few data 
available for this area, at each quarter the average of all available alcohol prices at the 
different CPI areas is taken and used in place of the DC data.  Several places are 
affected .by this mapping. 
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(NON-DRUG VARIABLES) 
LABEL  VARIABLE  RESPONSE  SURVEY YEAR 
le82  101  loo0  loo1  1992  1993 
4  IW  4  4  4  4 
onex 
1-  aex fmm 
2-wxtdtenfmn  2-mxhkanfmn 2-mxfrom  2-wxfmn 
I-  aex fmm 
wum  Rle  questbmalm  4  4  4  4 
nla  eauener  auwnar  mler  lcaw 
3=  wx 
IlatlslkAIy 
na  nla  nla 
nla  nla  nla  nla  nle 
1WA  19948  1005  1oW 
4  4  4  4 
hmx  hdcator  n1.x  1-  wx horn qu&lomalra 
2- aex fmn rnlatlmatb  on mrter 
4  4  4  4 
3-  wx  fmm Mer 
4-  aex atatistlcally hpuled  nla  nla  nle  nla 
4  4  4  4 
hnputatlm  mvlsed age of 
respondant  Iraga  Sge  f  4  4  4  4  4 
11  age fmm  I=  age caldated 
Z= age taken fmm 
hnge Indccllor  nag.  I=  age fmm blrlhdale  wum  nie  tmmquestlaalre  4  4 
ZE  age fmm wver d  quesclmnalm  nla  ncmener 
32  age fmm meter  nle  32agehpuled  auwnar 
Sagelakenfmn 
4-  aga  alalllsclcaiiy lmpuled udng ages gr horn mrtf nla  nla  bawwd  , 
4  4  4  4  4  4 
last grade cunpleled in 
school  dUC  o=no  schooling 
1-first grade ....  12=twemhgrada 
13;. fmhmanl13m year 
14s aophamnJ 14U1 year 
15-  junior/ 15!h year 
1  tb  senlor/ 18m year 
17= graduate‘ prolesalonal xhod (or  higher) 
85- bad  data (hgkaly aatdgmd) 
!M=  don7  kww 
97= refused 
98- blank (no  a~~r) 
99-  Iedllmata  skip 
4  4  4  f  4  f 
nla 
nl. 
nla 
nla 
nla 
nle 
n/a 
nla 
nla  nfa  nle  nla  nle 
4 
nla 
4 
nfa 
4  4 
nla 
4  4  4 
nla 
nl1 
nla  nla  nla 
nla  nla  nla 
nla 
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(NOKDRUG  VARIABLES) 
UBEL  VARIABLE 
wrrenl matltfd d.hm  marttrl 
RESPONSE  SURW  YEAR 
looi  IOW 
4  4 
1062  IWO 
1- manled  4 
2-  lMng 8.9  8 Couple 
3pwlbOwed 
S=  rwnrer manled 
nla 
nla  nla 
nla 
nla 
4= tmvawd w separated 
loo0 
4 
1991 
4 
ISMA 
J 
19948 
4 
In5  1oDs 
4  4 
nla 
nla  nla  nla  nla 
nla 
nla 
nla  nla  nla 
"i 
4  4  4  4  J  4  4  4 
J  4  4  4  4  4  J  4 
3 fnnn 1994A  3 hum 1994A  3 hum 1994A  3- haw  lob bul out:  lllnesd lea&  (wkughl mtlka 
4 from 1994A  4 hum 1994A  4 hum 1994A  4s unemployed orlald df  andloddngforwwk 
Sfrom1994A  Shuml994A  Shum1994A  sIunemployedandnotloddngforwo* 
8from1994A  8ha1994A  8hom1994A  B..M)thmhomem&eraJy 
7hum1994A  7hum1994A  7fmn1994A  7rInschoolaJy 
8from1994A  Bhum1994A  8huml994A  Brntlrsd 
9fromlMA  9ha1994A  9hum1994A  %dabled,ndabbtowoI(( 
10fmm1994A lOtrwn1994A lOffomlW4A lO=ohr,inlaborfcnce 
11 (ran l9MA 11 (ran 1994A 11 (ran 19MA 1  I=  other, nd In labor fcnce 
nla  nla  nh  nla 
1s  working fuCUme. 35  houra or mm  a week 
2= woldng part-time. lets3 than 35  hours a week 
3=  haw a lob. bul nd  at work llkresslmatamily 
b  have a lob bul no( at work Wc It Is aemal 
sI unemployed w laM On and loddng for work 
6-  unemployed w Idd cfl and not kdthgforwork 
7-  MI tlme homemaker 
IbInachootonly 
9s re(lred 
IO= disabled for work 
ll=  other, in labor fence 
129 other, not  In labor force 
15  full Ume 
2s part tlme 
3r  unemployed 
4;.  other 
SI 12-17 year olds 
3  from 1994A 
4 hum 1994A 
Sfrom1994A 
6 han 1994A 
7from 1994A 
8 from 1994A 
9 from 1994A 
10  from 1994A 
11 horn 19MA 
&I 
4  4  J  4  4  4  4  4  4 
war been In the US 
Armed Fom  8OWkO  4  4  4  4  J  J  4 
nla 
nla 
nla 
nla 
nla  nla 
nh 
nla  nla 
nh 
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UBEL  VARIABLE  RESPONSE  SURVEY YEAR 
loo*  1892  looJ  lWA  10010  199s 
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(DRUG VARIABLES) 
VARIABLE  LABEL 
MARIJUANA 
age when first used marijuana/ hashish  mjqo 
x days  used rnjl hashish past 12 months  miydmq 
# days used  myhashish in past 30  days  mJday3Om 
COCAINE 
age when first used cocaha  - 
x days  used cocaine past 12 monm  cocyr(q 
x days used cocalne in past 30  days  cocuwo. 
CRACK 
age when first used crack  crwP 
w days  used crack in past 12 months  crkymq 
# days  used  crack  past 30  days  clku.30. 
RESPONSE 
age 
999=  never used marijuana/ never used ml (logically assigned) 
.  = missing 
I=  more then  300 days (severat times  a by  in past year/ dait; hthe past par) 
2;. 101 to  3OOdsys (almost dally or 3to 6 dayoa wwk) 
3=51b100days(1  or2dapawek) 
4t 25 to 50 days  (severa times a month 1h~t25to  51 days a year) 
5e 12 to24dap  (1 or2  timer a month) 
6=  6 to 11 days (every 0th~  month or so) 
7= 3 to5days in the  past 12 monthr 
8=1 to2dayshthepast12mofm 
9= did not use mj past 12 months  (lcgicdlyauignedydid  not use mJ in past 12 months 
W9= never used mj (logically assignedy never used mj 
.  = mbsing 
number 
W9= never used mj (logically assignedynever used mj 
.  = misslng 
aP 
ggg.  never used cocalnelnwer used cocahe (kglca))yass@ed) 
.  = mbslng 
I= mom than  300  daysl(dally h  past year) 
2s 101 to 300  daysl (abnostdallyor3to 6 days a wek) 
3=  51 to 100 dayd (1 or2  days  a mk)  . 
G  25  to  50 dayd (several times a monlh abwt 25  to  51 days a par) 
!k  12 to 24 dayd (1 or 2 timer  a month) 
6= 6 to  11 days ( WeCy OUW  month OI  80) 
71  3 to  5 days in the past 12 monlf~S 
8= 1  to2 days h  the past 12 monUu 
9=  did not use cocaine In past 12 months (loglcaHy astlgned)/dld not  use cocsine in past 12 mod 
W9= new  used cocald  never used cocaine (bgically uslgned) 
.  = missing 
number 
999= never used cocaine (logically asignedy never used cocaha 
.  = missing 
age 
999= never used cradd never used aack (bgkaNy aaslgned)  .  = missing 
I= mom then 300  days (every day or almost every day) 
3=51tolOodaya(l to2daysaweek) 
G  25 to  Sodays (310 4days awe&) 
5= 12 to  24 days  (1 to  2  days  a mow) 
6=  6 to 11 days (h  tian onedayr month) 
2= 101 to  300  days  (3  to6 days a W) 
7= used s5dayo in past 12 molllha 
&used  1-2daysinthepast12~ 
9=  did nol uo  crack h  past 12 monthddid not una crack put12  m0nma (bgicallyasdgned) 
899= never used crack/  never used as&  (kglcaly  assigned) 
.  = missing 
avs 
.  = mirsing 
never used craddnever usedasck (bgicaNyasdgned) 
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LABEL  ' 
most recent time used aack 
VARIABLE 
CnIWC 
I  vink  of  aackused h  past 30  daya  crlum3Oa 
ever used clackdaily loc 2 or mwe weeka  eWIdaly 
HEROIN 
age when first used heroin 
# days  used herdn In past 30 days  lmr3ouM 
ALCOHOL 
age when had first ddnk of alcohdk 
beverage 
frequency of alcohol consumptkn in past 
12 months  alcp.1 
# days  had one  or more  drink past 30  alcdyr 
TOBACCO 
age when first smoked a cigarelte  CWY 
age when first started  smoking 
cigarettes everyday  ci9w 
number cigarettes smoked per day past 30 
avcig 
I  RESPONSE 
1-  within the past 30 dayd use h  past 30  days-  logicakylmputed 
2= more lhan %days ago but wllhin the  past 12 months 
3=  more than 12 montha ago butwWlin  the  past 3  yean 
4=  more than 3 years ago 
SI use  In past year- kglally imputed 
6=  use  In  lifetime- bgicany lmpured 
998=  never used cmck- b@csty  adgnecUnever used aadc 
.  = mbslng 
Nlos 
9BD= new  used  crack-  bgkaily aaslgnedl never used  crack 
.=missing 
a- 
99% never used heroW new  wed heroin (logically asdgned) 
.  L  missing 
number 
99% never used heroin- logically assigned/ never used hemin 
.  = misslng 
99% never used alcohov never used alcohol (logically assigned) 
.  = mMng 
1s more than 300  days (every day  or almost every day/  daily) 
2= 101 to 300  days (3  (0 6 days  a wed  almost dally) 
3=  51 to 100 days (1 or2  days  a week) 
G  several timer  8 month (about 2551 days  a year) 
5= 12 to 24 days  (1 to 2 days a month) 
6=  6 to 11 days  (less than one day a mo&every  other month orro) 
7= 3 b  5 dap  h  the  past 12 monmS 
8= 1 to 2 daya h  the  past 12 monthr 
9=  did not use  alcohol h  past 12 monthd did  not use  alcohol in past 12 months (bgicalty assigned, 
99% never used alcohoU never used  alcohol (logically assigned) 
.  = mlssing 
davs 
99% never used alcohol (logically assigned~  never used alcohol 
.  = rnbsing 
age 
999=  never used cigarenesl never used  dgaretts (logiilly assigned) 
.  = missing 
age 
999= never used cigareliesl never used cigarettes- (logically assigned); never used 
cigarettes every day/ never used cigarettes every day (logically assigned) 
.  = missing 
O= did  not use  cigarem in past 30 dayd did not use  cigarettes in past 30  days  (logically assigned 
1= at leest a puff but less lhanonecig  eachday 
2= 1  (0 5 cignretws each day 
3=  6 to 15 cigarettes (about 1R pack)  each day 
4= 16 to 25 cigarettes (about 1 pack) each day 
5=  26 to 35  cigarettes (about  1 1R packs) each day 
6= 35 or mom cigarettes (about  2 packs) each day 
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NATIONAL HOUSEHOLD SURVEY RESPONSES AFTER RECODING 
(DRUG VARlAB  LES) 
VARIABLE 
number yean smoked dQarettes  every day  clgym 
number months smoked number cigamtba 
My  In  avdg  cwm 
I 
RESPONSE 
99%  never used clganmed newer used  cigarettes- bgkdly  asslgned 
.  = mbrdng 
m 
O= smoked dgamttes every day but only for less than 1 yrl  never used cigarettes every day/ 
never used cigarettes every day-  logically assigned 
9W=  never used clgareaad  never used cigarettes- logically asslgnmd 
.  = mbhg 
l=  @yes-  ksicalv 0- 
o=m 
99%  never wed clgamaad  never used dgarettes- loglcalty assigned 
.  = missing 
1=  one  to five dgarettes a dry 
2-  about 1R pack I day (e15 eigaretba) 
3=  lbwta packa Qy  (le25  dgamtbw) 
4= about  1 1R pa*  I  day  (2C35  dgareltes) 
5= about2  packs or mom o &y(over35  dgaretks) 
999= never used CigareW never used cigarettes- logically asdgmd 
.  = missing 
O=nomonths 
99%  never used dgareaer/ never used dgamtks- logically arslgnsd 
.  = missing 
i 
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(NON-DRUG VARIABLES) 
LABEL  VARIABLE 
primary sampling unl  (enaypted)  mpr" 
segment identification number (encrypted)  encwg 
household levd Identification number 
(=vPw  0- 
intervbw mOnm  lntmonth 
risk W use cocabmonce a month  rnLcococc 
totel personal hawn,  recode (13 
categories)  w-w 
total family income recode (13  categories)  hm-lnc 
RESPONSE 
code 
code 
code 
1-12 mneopond lo monms 
l=nOliSk 
2= dbht tisk 
3=  moderate rlsk 
.  = missing 
4=  gmt  rwc 
l=nOliSk 
2= sliiht rbk 
3=  moderate risk 
4=  great rbk 
.  = missing 
l=nOrbk 
2= slight rbk 
3=  moderate rlsk 
&  great rwc 
.  = missing 
1= no  tisk 
2= slight r(dc 
32  moderate dsk 
.  = missing 
4= great rwc 
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healthhgenenl 
NATIONAL HOUSEHOLD SURVEY RESPONSES AFTER RECODING 
(NON-DRUG VARIABLES) 
VARLABLE  RESPONSE 
fendepressed2  weeks or more in past 12 
months  dw- 
I weeks felt depressed h  past 12 months  d.pw*rl 
W0ni.d 
# months before anxiety ended- reatdo  womomol 
is We  usual ptace for health care  U-U 
covered by private lnsuranat or hmo  pwhMn 
private health insurate plan or hmo indude 
coverage for trealment for alcohol abuse or 
alcoholism  hltlnrk 
private health insurate plan or hmo  indude 
coverage for  treatment for drug abuse  hltindq 
private health insurate plan or hmo inClyde 
coverage foc treatment for mental or 
emtionel diffiilties  hltlnmnt 
l=  Wthere  b  morelhanone place 
@no 
.  = missing 
I= yes 
O=m 
.  = missing 
l=  yes 
O=m 
.  = missing 
kyes . 
&no 
.  = missing 
halulcprl If hltlnok io 'iegMma(e aklp' 
1= yes 
&no 
.  = missing 
hmntskp-1  If hltlnmnt is 'kgwlmats aklp' 
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(NON-DRUG VARIABLES) 
UBEL 
rad  hispankorigin recoda 
aex- Imputation revised 
lraex indicator 
VARUBLE 
whb 
OUWC 
imputation revised age of respondent  lng. 
lrage indicator  1- 
last grade completed In school  duc 
evidence of high school completion (Have 
you received a hs diploma. or  a OED 
wrticlcate of hs completion?)  dip- 
wnent marital status 
work status- imputation indicator 
mnkd 
dlwd 
RESPONSE 
le  yes,  ram-bladc 
&no 
I=  yes. ram- hispank 
Ckno 
I=  yes.  other raw (not  white.  not black, not hispanic) 
Ckno 
l=  mab 
O= female 
1  =  sex from questknnalrd sex from soum  file 
2- sex from relatknsNp on mtar 
3=  sex from roster 
c-  sex rtatbucany imputed 
5= sex from sawnor 
l=agefromMtthdaW  . 
2=  age trom  wver of  quedbnnalrd  age from source fib/ age cakulakd 
3=agefromrosW 
4.  age statislkalty Imputed using ages gr  hom rostar/ age bnputai 
5= age taken from screaner 
frOmq~Mk0 
Qno - 
1- ntxt grade.... 12=  twelflh grads 
13=freshmanll3thyear 
14= sophomore/ 14lh year 
15  Junlorl15th  ywaf 
16= seenbrl161h year 
17=  graduate/ professional school (or higher) 
.  = m4ssing 
educa@=l I  .due  waa 'bgitlnuta .kip' 
1  = divorced 
o=- 
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LABEL 
work status-  imputation revised 
VARIABLE 
ImOr(ut 
employment stetus recode 
Are  you a veteran or a cunent member of 
the  armed forms?  WbWm 
RESPONSE 
1= Working hrl!-ti~.  35  houM Of  mOre 0 wsdc 
2= woking part-time. less than 35  bun  a week 
3=  have a job. but nol at work. illnesdmabmity 
' 4= have a job but not  at work blc i~ Is seasonal 
5= unempbyedor laid off and Wng  br  work 
6=  unemployed or laid off and not Wng  lor work 
7= fun thne  homem~lker 
&Inschooronly 
Q=  retired 
1O=dlsclbkdfOrwork 
11= other. In hbor  force 
12s other. no!  In hbor fora, 
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Loglikelihood Function 
We want to estimate three equations 
I  =  zp+u 
lnt  =  Xa+r 
d‘  =  Yy+u 
Probability of  using drug when t +  +oo is determined by equation (1). The 
probability is 
’  -  with density function g(Z@). 
The random variable u is assumed  to be independent of  e and v,  while 
r  and  v are assumed to be bi-normal  with standard-deviations a, and a,,, 
and correlation coefficient t. Denote the CDF and PDF of  standard normal 
distribution by  ip and 6,  respectively.  Then the conditional distribution of 
d’  given lnt is 
Assume there are n categories of  drug use for the group of  people who 
tried drug in the past.  Including the interval of  non-use, there are n cut-off 
points. 
Note that we  set 
P-l=-CQl  Po=o,  p,=+w. 
Denote the current age by  age and the age of  the first use of  drug by  tt. 
Denote the set of  persons who tried  drug in the past  by E and  the set of 
persons who never tried drug by  N.  The log-likelihood function is 
121 
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Lr =  In [c(Za)  (1 -  @ (  Inage  -  x")) +  (1 -  G(Z@))]  (4) 
0, 
I 
and  l 
where I'(k) = 1  if  person i is in kth category; Ii(k)  =  0 otherwise. 
So we set 
Note that the parameters 7 can only be identified up to a fraction of a,,. 
a,, = 1. 
Also we transform r and u, according to 
2 
u, =  ev,  r = -  arctan(() 
lr 
so  that q and 
and t  in (-1,l). So the parameters to be estimated are 
can change freely on the real line while keeping ut positive 
Gradients 
First we calculate the gradients of  Ly with respect to cr,P and q. Define 
In age -  Xa 
ev  Ba E 
A  G(ZD)  (1 -  @(Ba))  + (1 -  G(ZD)) 
PROPERTY OF 
National Criminal Justice Reference Service (NCJRS) 
Box 6QQO 
Rock~i!le.  KID  2084G-EOOQ 
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We define the following notations. 
LE  =  lnG(ZP) +  ln$(Bj) -  q -  lntj +  1nC. 
So we have 
-  DY 
B; +  TDB, -  1 
123 
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